{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pyspark.sql import SparkSession, Window\n",
    "import pyspark.sql.functions as F\n",
    "from datetime import datetime\n",
    "from datetime import date\n",
    "from pyspark.sql.types import StructType, StructField, StringType, IntegerType\n",
    "from pyspark.sql.types import (\n",
    "    StructType,\n",
    "    StructField,\n",
    "    DoubleType,\n",
    "    DecimalType,\n",
    "    StringType,\n",
    "    FloatType,\n",
    ")\n",
    "\n",
    "spark = SparkSession.builder.getOrCreate()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Load the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "platform_v = \"24.09\"\n",
    "\n",
    "chembl = spark.read.parquet(\n",
    "    f\"gs://open-targets-data-releases/{platform_v}/output/etl/parquet/evidence/sourceId=chembl\"\n",
    ")\n",
    "\n",
    "target_path = (\n",
    "    f\"gs://open-targets-data-releases/{platform_v}/output/etl/parquet/targets/\"\n",
    ")\n",
    "target = spark.read.parquet(target_path)\n",
    "\n",
    "diseases_path = (\n",
    "    f\"gs://open-targets-data-releases/{platform_v}/output/etl/parquet/diseases/\"\n",
    ")\n",
    "diseases = spark.read.parquet(diseases_path)\n",
    "\n",
    "indications_path = (\n",
    "    f\"gs://open-targets-data-releases/{platform_v}/output/etl/parquet/indication/\"\n",
    ")\n",
    "indications = spark.read.parquet(indications_path)\n",
    "\n",
    "path_s01 = \"gs://ot-team/jroldan/GIR_S01.csv\"\n",
    "nelson = spark.read.csv(path_s01, header=True)\n",
    "\n",
    "path_mapping = \"gs://ot-team/jroldan/mappings.csv\"\n",
    "mapping = spark.read.csv(path_mapping, header=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'mapping' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m/tmp/ipykernel_266243/663704443.py\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mn\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mmapping\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mcount\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      2\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"There are\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mn\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m\"mappings from EFO to MeSH terms\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
      "\u001b[0;31mNameError\u001b[0m: name 'mapping' is not defined"
     ]
    }
   ],
   "source": [
    "n = mapping.count()\n",
    "print(\"There are\", n, \"mappings from EFO to MeSH terms\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### What heppens with the obsolete terms used in the mappings Mesh-EFO?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+------------+\n",
      "|            id|         col|\n",
      "+--------------+------------+\n",
      "|   EFO_0000508|MeSH:D030342|\n",
      "|   EFO_0001054|MeSH:D007918|\n",
      "|   EFO_0004287|MeSH:D014693|\n",
      "|   EFO_0004302|MeSH:D000886|\n",
      "|   EFO_0007185|MeSH:D002006|\n",
      "|   EFO_0007225|MeSH:D015605|\n",
      "|   EFO_0007504|MeSH:D013587|\n",
      "|   EFO_0009536|MeSH:D001762|\n",
      "|   EFO_1000982|MeSH:D007177|\n",
      "|   EFO_1001117|MeSH:D017562|\n",
      "|   EFO_1001175|MeSH:D010302|\n",
      "|   EFO_1001762|MeSH:D020211|\n",
      "|   EFO_1002002|MeSH:C535833|\n",
      "| Orphanet_2597|MeSH:C537476|\n",
      "| Orphanet_3020|MeSH:C535287|\n",
      "|Orphanet_73217|MeSH:C537371|\n",
      "|   EFO_0003902|MeSH:D016103|\n",
      "|   EFO_0005583|MeSH:D012279|\n",
      "|   EFO_0007136|MeSH:D000377|\n",
      "|   EFO_0007413|MeSH:D010002|\n",
      "+--------------+------------+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "diseases.select(\"id\", F.explode_outer(F.col(\"dbXRefs\").alias(\"xrefs\"))).filter(\n",
    "    F.col(\"col\").contains(\"MeSH\")\n",
    ").show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "6412"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "diseases.filter(F.expr(\"exists(dbXRefs, x -> x rlike '(?i)MeSH')\")).count()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Make dataset where diseases are annotated with their respective MeSH terms. For those conflicting, we take the Mesh1."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "diseasesWithAnnotations = (\n",
    "    diseases.withColumn(\n",
    "        \"mesh1_flag\",\n",
    "        F.expr(\"filter(dbXRefs, x -> x rlike 'MeSH')\")[\n",
    "            0\n",
    "        ],  # Extract the matching element\n",
    "    )\n",
    "    .withColumn(\n",
    "        \"MESH2_flag\",\n",
    "        F.expr(\"filter(dbXRefs, x -> x rlike 'MESH')\")[\n",
    "            0\n",
    "        ],  # Extract the matching element\n",
    "    )\n",
    "    .withColumn(\"cleaned_mesh1\", F.regexp_replace(F.col(\"mesh1_flag\"), \"(?i)MeSH:\", \"\"))\n",
    "    .withColumn(\"cleaned_mesh2\", F.regexp_replace(F.col(\"MESH2_flag\"), \"(?i)MeSH:\", \"\"))\n",
    "    .withColumn(\n",
    "        \"equalOrNot\",\n",
    "        F.when(\n",
    "            (F.col(\"cleaned_mesh1\").isNotNull()) & (F.col(\"cleaned_mesh2\").isNotNull()),\n",
    "            F.when(\n",
    "                F.col(\"cleaned_mesh1\") == F.col(\"cleaned_mesh2\"), F.lit(\"equal\")\n",
    "            ).otherwise(F.lit(\"diferent\")),\n",
    "        )\n",
    "        .when(\n",
    "            (F.col(\"cleaned_mesh1\").isNotNull()) & (F.col(\"cleaned_mesh2\").isNull()),\n",
    "            F.lit(\"mesh1\"),\n",
    "        )\n",
    "        .when(\n",
    "            (F.col(\"cleaned_mesh1\").isNull()) & (F.col(\"cleaned_mesh2\").isNotNull()),\n",
    "            F.lit(\"mesh2\"),\n",
    "        )\n",
    "        .when(\n",
    "            (F.col(\"cleaned_mesh1\").isNull()) & (F.col(\"cleaned_mesh2\").isNull()),\n",
    "            F.lit(\"noData\"),\n",
    "        ),\n",
    "    )\n",
    "    .withColumn(\n",
    "        \"unionMesh\",  ### when they are different, take the cleaned_mesh1\n",
    "        F.when(F.col(\"equalOrNot\") == \"equal\", F.col(\"cleaned_mesh1\"))\n",
    "        .when(F.col(\"equalOrNot\") == \"mesh1\", F.col(\"cleaned_mesh1\"))\n",
    "        .when(F.col(\"equalOrNot\") == \"mesh2\", F.col(\"cleaned_mesh2\"))\n",
    "        .when(F.col(\"equalOrNot\") == \"diferent\", F.col(\"cleaned_mesh1\")),\n",
    "    )\n",
    "    .withColumn(\n",
    "        \"hasMeshData\",\n",
    "        F.when(F.col(\"unionMesh\").isNotNull(), F.lit(\"yes\")).otherwise(F.lit(\"no\")),\n",
    "    )\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 38:===================>                                      (1 + 2) / 3]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-----------+------------+\n",
      "|         id|         col|\n",
      "+-----------+------------+\n",
      "|EFO_0000508|MESH:D030342|\n",
      "+-----------+------------+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "diseases.select(\"id\", F.explode_outer(F.col(\"dbXRefs\").alias(\"xrefs\"))).filter(\n",
    "    F.col(\"col\").contains(\"MESH\")\n",
    ").filter(F.col(\"id\") == \"EFO_0000508\").show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 26:===========================================>              (6 + 2) / 8]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-----------+-----+\n",
      "|hasMeshData|count|\n",
      "+-----------+-----+\n",
      "|         no|21915|\n",
      "|        yes| 6412|\n",
      "+-----------+-----+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "diseasesWithAnnotations.groupBy(\"hasMeshData\").count().show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+------------+\n",
      "|           id|         col|\n",
      "+-------------+------------+\n",
      "|  EFO_0000255|MESH:D007119|\n",
      "|  EFO_0000508|MESH:D030342|\n",
      "|  EFO_0001054|MESH:D007918|\n",
      "|  EFO_0004287|MESH:D014693|\n",
      "|  EFO_0007185|MESH:D002006|\n",
      "|  EFO_0007225|MESH:D015605|\n",
      "|  EFO_0007504|MESH:D013587|\n",
      "|  EFO_0009536|MESH:D001762|\n",
      "|  EFO_1000982|MESH:D007177|\n",
      "|  EFO_1001117|MESH:D017562|\n",
      "|  EFO_1001175|MESH:D010302|\n",
      "|  EFO_1001913|MESH:D055665|\n",
      "|MONDO_0002977|MESH:D020274|\n",
      "|MONDO_0004532|MESH:D004428|\n",
      "|MONDO_0005301|MESH:D009103|\n",
      "|MONDO_0007159|MESH:C535386|\n",
      "|MONDO_0007592|MESH:C565028|\n",
      "|MONDO_0007683|MESH:C537293|\n",
      "|MONDO_0007891|MESH:C573023|\n",
      "|MONDO_0007915|MESH:D008180|\n",
      "+-------------+------------+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    }
   ],
   "source": [
    "diseases.select(\"id\", F.explode_outer(F.col(\"dbXRefs\").alias(\"xrefs\"))).filter(\n",
    "    F.col(\"col\").contains(\"MESH\")\n",
    ").show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Process datasets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "### prepare mapping EFO-MeSH dataset  (#2,320 pairs)\n",
    "mappings = (\n",
    "    mapping.withColumn(\n",
    "        \"efo_column\",\n",
    "        F.regexp_replace(F.col(\"curie_id\"), \":\", \"_\"),  # Replaces \":\" with \"_\"\n",
    "    )\n",
    "    .withColumn(\n",
    "        \"mesh_column\",\n",
    "        F.regexp_replace(\n",
    "            F.col(\"mapped_curie\"), \"^MeSH:\", \"\"\n",
    "        ),  # Removes \"MeSH:\" from the start\n",
    "    )\n",
    "    .selectExpr(\"label\", \"efo_column\", \"mesh_column as indication_mesh_id\")\n",
    ")\n",
    "### Get csv from Nelson and join bring EFO column to MeSH terms\n",
    "nelson_efo = (\n",
    "    nelson.join(mappings, on=\"indication_mesh_id\", how=\"left\")\n",
    "    .withColumn(\"diseaseId\", F.col(\"efo_column\"))\n",
    "    .withColumnRenamed(\"target\", \"approvedSymbol\")\n",
    ")\n",
    "### Make chembl T-D-MaxClinPhase pairs and join with approved Symbol\n",
    "chemblTD = (\n",
    "    chembl.groupBy(\"targetId\", \"diseaseId\")\n",
    "    .agg(F.max(F.col(\"clinicalPhase\")).alias(\"ChEMBL_maxClinPhase\"))\n",
    "    .join(\n",
    "        target.selectExpr(\"id as targetId\", \"approvedSymbol\"), on=\"targetId\", how=\"left\"\n",
    "    )\n",
    ")\n",
    "#### Join Nelson dataset T-I-MaxClinPhase mapped to EFO with Chembl pairs\n",
    "matches = nelson_efo.join(chemblTD, on=[\"approvedSymbol\", \"diseaseId\"], how=\"outer\")\n",
    "matches_inner = nelson_efo.join(\n",
    "    chemblTD, on=[\"approvedSymbol\", \"diseaseId\"], how=\"inner\"\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "25713"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nelson.count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+---------+------------------+-----+\n",
      "|diseaseId|combined_max_phase|count|\n",
      "+---------+------------------+-----+\n",
      "|     null|       Preclinical| 2892|\n",
      "|     null|          Launched|  465|\n",
      "|     null|           Phase I| 1119|\n",
      "|     null|         Phase III|  476|\n",
      "|     null|          Phase II| 1957|\n",
      "+---------+------------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "nelson_efo.filter(F.col(\"diseaseId\").isNull()).groupBy(\n",
    "    \"diseaseId\", \"combined_max_phase\"\n",
    ").count().show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "# matches.toPandas().to_csv(f\"gs://ot-team/jroldan/analysis/matchesNelsonChembl_all.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Dataset with T-D with the annotation of being approved (if having at least one drug with approved drug label)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "#### let's take the maximum (approved indication) for each target-disease\n",
    "indiLabelapproved = (\n",
    "    chembl.selectExpr(\"drugId as Id\", \"targetId\", \"diseaseId\")\n",
    "    .join(\n",
    "        indications.select(\n",
    "            \"id\",\n",
    "            F.explode_outer(F.col(\"approvedIndications\")).alias(\"diseaseId\"),\n",
    "        ).withColumn(\"approved\", F.lit(\"approvedIndication\")),\n",
    "        on=[\"id\", \"diseaseId\"],\n",
    "        how=\"left\",\n",
    "    )\n",
    "    .sort(F.col(\"Id\").desc())\n",
    "    .withColumn(\n",
    "        \"approvedDrugName\",\n",
    "        F.when(\n",
    "            F.col(\"approved\") == \"approvedIndication\",\n",
    "            F.collect_set(F.col(\"Id\")).over(\n",
    "                Window.partitionBy(\"targetId\", \"diseaseId\")\n",
    "            ),\n",
    "        ).otherwise(F.lit(None)),\n",
    "    )\n",
    "    .groupBy(\"targetId\", \"diseaseId\", \"approved\")\n",
    "    .count()\n",
    "    ### take T-D with at least one approved drug label\n",
    "    .filter(F.col(\"approved\") == \"approvedIndication\")\n",
    "    .join(\n",
    "        chembl.withColumn(\n",
    "            \"maxClinPhase\",\n",
    "            F.max(\"clinicalPhase\").over(Window.partitionBy(\"targetId\", \"diseaseId\")),\n",
    "        )\n",
    "        .select(\"targetId\", \"diseaseId\", \"maxClinPhase\")\n",
    "        .distinct(),\n",
    "        on=[\"targetId\", \"diseaseId\"],\n",
    "        how=\"right\",\n",
    "    )\n",
    "    .join(\n",
    "        target.selectExpr(\"id as targetId\", \"approvedSymbol\"), on=\"targetId\", how=\"left\"\n",
    "    )\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Once we have the proxy of approved drug labels, we should map diseases to Mesh terms\n",
    "    1. Using the dbXRefs (check number of mapped terms)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### check numbers of T-D with mapped EFO to MEsh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 31:======================================>                   (2 + 1) / 3]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-----------+-----+\n",
      "|hasMeshData|count|\n",
      "+-----------+-----+\n",
      "|         no|31359|\n",
      "|        yes|50006|\n",
      "+-----------+-----+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").groupBy(\"hasMeshData\").count().show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Check numbers of diseases with mapped EFO to Mesh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 42:======================================>                   (2 + 1) / 3]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-----------+-----+\n",
      "|hasMeshData|count|\n",
      "+-----------+-----+\n",
      "|         no| 1294|\n",
      "|        yes| 1566|\n",
      "+-----------+-----+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").select(\"diseaseId\", \"hasMeshData\").distinct().groupBy(\"hasMeshData\").count().show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Bring Nelson analysis (just interesting columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-----------+-----+\n",
      "|hasMeshData|count|\n",
      "+-----------+-----+\n",
      "|       null|19847|\n",
      "|         no|31359|\n",
      "|        yes|50006|\n",
      "+-----------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").join(\n",
    "    nelson.selectExpr(\n",
    "        \"target as approvedSymbol\",\n",
    "        \"indication_mesh_id as unionMesh\",\n",
    "        \"combined_max_phase\",\n",
    "    ),\n",
    "    on=[\"approvedSymbol\", \"unionMesh\"],\n",
    "    how=\"outer\",\n",
    ").groupBy(\n",
    "    \"hasMeshData\"\n",
    ").count().show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indi_inner = indiLabelapproved.join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").join(\n",
    "    nelson.selectExpr(\n",
    "        \"target as approvedSymbol\",\n",
    "        \"indication_mesh_id as unionMesh\",\n",
    "        \"combined_max_phase\",\n",
    "    ),\n",
    "    on=[\"approvedSymbol\", \"unionMesh\"],\n",
    "    how=\"inner\",\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "6047"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "indi_inner.count()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Differences between maxClinPhase and combined_max_phase"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "indi_inner_plot = indi_inner.groupBy(\"maxClinPhase\", \"combined_max_phase\").count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "table = indi_inner.groupBy(\"maxClinPhase\").pivot(\"combined_max_phase\").count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "#### column order\n",
    "col_order = [\n",
    "    \"maxClinPhase\",\n",
    "    \"Phase I\",\n",
    "    \"Phase II\",\n",
    "    \"Phase III\",\n",
    "    \"Preclinical\",\n",
    "    \"Launched\",\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['maxClinPhase', 'Launched', 'Phase I', 'Phase II', 'Phase III', 'Preclinical']"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "table.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "toPlotHeatmap = (\n",
    "    indi_inner.groupBy(\"maxClinPhase\")\n",
    "    .pivot(\"combined_max_phase\")\n",
    "    .count()\n",
    "    .select(*col_order)\n",
    "    .sort(F.col(\"maxClinPhase\").asc())\n",
    "    .toPandas()\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:>"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.heatmap(toPlotHeatmap)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'sns' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[0;32m/tmp/ipykernel_508880/1698026354.py\u001b[0m in \u001b[0;36m<cell line: 1>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mglue\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0msns\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mload_dataset\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"glue\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mpivot\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mindex\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"Model\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mcolumns\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"Task\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mvalues\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"Score\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[0;31mNameError\u001b[0m: name 'sns' is not defined"
     ]
    }
   ],
   "source": [
    "glue = sns.load_dataset(\"glue\").pivot(index=\"Model\", columns=\"Task\", values=\"Score\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "glue"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "glue = sns.load_dataset(\"glue\").pivot(index=\"Model\", columns=\"Task\", values=\"Score\")\n",
    "sns.heatmap(glue)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "toPlotInner = indi_inner_plot.sort(F.col(\"maxClinPhase\").desc()).toPandas()\n",
    "\n",
    "sankey(\n",
    "    left=toPlotInner[\"maxClinPhase\"],\n",
    "    right=toPlotInner[\"combined_max_phase\"],\n",
    "    leftWeight=toPlotInner[\"count\"],\n",
    "    rightWeight=toPlotInner[\"count\"],\n",
    "    aspect=20,\n",
    "    fontsize=20,\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### Count combination sof max clin phase, approved and combined max clin phase from Nelson "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 169:======================================>                  (2 + 1) / 3]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+------------------+------------------+------------+-----+\n",
      "|          approved|combined_max_phase|maxClinPhase|count|\n",
      "+------------------+------------------+------------+-----+\n",
      "|approvedIndication|              null|         1.0|   45|\n",
      "|approvedIndication|       Preclinical|         3.0|    1|\n",
      "|              null|           Phase I|         1.0|  283|\n",
      "|approvedIndication|          Launched|         2.0|    9|\n",
      "|approvedIndication|              null|         3.0|  454|\n",
      "|approvedIndication|       Preclinical|         4.0|  193|\n",
      "|              null|          Phase II|         2.0| 1265|\n",
      "|              null|         Phase III|         1.0|   52|\n",
      "|approvedIndication|          Phase II|         3.0|    1|\n",
      "|approvedIndication|          Phase II|         2.0|    3|\n",
      "|approvedIndication|           Phase I|         2.0|    1|\n",
      "|              null|          Phase II|         0.5|   14|\n",
      "|              null|       Preclinical|         2.0|  395|\n",
      "|approvedIndication|       Preclinical|         2.0|    1|\n",
      "|              null|              null|         1.0|13007|\n",
      "|              null|           Phase I|         0.5|    2|\n",
      "|approvedIndication|           Phase I|         4.0|  132|\n",
      "|              null|           Phase I|         2.0|  290|\n",
      "|              null|              null|         4.0|14916|\n",
      "|              null|           Phase I|         4.0|   94|\n",
      "+------------------+------------------+------------+-----+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").join(\n",
    "    nelson.selectExpr(\n",
    "        \"target as approvedSymbol\",\n",
    "        \"indication_mesh_id as unionMesh\",\n",
    "        \"combined_max_phase\",\n",
    "    ),\n",
    "    on=[\"approvedSymbol\", \"unionMesh\"],\n",
    "    how=\"outer\",\n",
    ").groupBy(\n",
    "    \"approved\", \"combined_max_phase\", \"maxClinPhase\"\n",
    ").count().show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Defaulting to user installation because normal site-packages is not writeable\n",
      "Collecting pySankey\n",
      "  Obtaining dependency information for pySankey from https://files.pythonhosted.org/packages/ad/fc/c2823db63e0efe3652759a4de2859ed02fe5479bb1ba720605cd789121e5/pySankey-0.0.1-py3-none-any.whl.metadata\n",
      "  Downloading pySankey-0.0.1-py3-none-any.whl.metadata (3.1 kB)\n",
      "Downloading pySankey-0.0.1-py3-none-any.whl (4.9 kB)\n",
      "Installing collected packages: pySankey\n",
      "Successfully installed pySankey-0.0.1\n"
     ]
    }
   ],
   "source": [
    "!pip install pySankey"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from pySankey.sankey import sankey"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "df2 = (\n",
    "    indiLabelapproved.join(\n",
    "        diseasesWithAnnotations.selectExpr(\n",
    "            \"id as diseaseId\", \"unionMesh\", \"hasMeshData\"\n",
    "        ),\n",
    "        on=\"diseaseId\",\n",
    "        how=\"left\",\n",
    "    )\n",
    "    .join(\n",
    "        nelson.selectExpr(\n",
    "            \"target as approvedSymbol\",\n",
    "            \"indication_mesh_id as unionMesh\",\n",
    "            \"combined_max_phase\",\n",
    "        ),\n",
    "        on=[\"approvedSymbol\", \"unionMesh\"],\n",
    "        how=\"outer\",\n",
    "    )\n",
    "    .groupBy(\n",
    "        \"approved\",\n",
    "        \"combined_max_phase\",\n",
    "    )\n",
    "    # \"maxClinPhase\")\n",
    "    .count()\n",
    "    .withColumn(\n",
    "        \"approved\",\n",
    "        F.when(F.col(\"approved\").isNull(), F.lit(\"noApproved\")).otherwise(\n",
    "            F.lit(\"approved\")\n",
    "        ),\n",
    "    )\n",
    "    .filter(\n",
    "        # (F.col(\"maxClinPhase\").isNotNull())\n",
    "        (F.col(\"count\").isNotNull())\n",
    "        & (F.col(\"combined_max_phase\").isNotNull())\n",
    "    )\n",
    "    .toPandas()\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df3 = df2[(df2[\"approved\"] == \"approved\")]\n",
    "\n",
    "sankey(\n",
    "    left=df3[\"combined_max_phase\"],\n",
    "    right=df3[\"approved\"],\n",
    "    leftWeight=df3[\"count\"],\n",
    "    rightWeight=df3[\"count\"],\n",
    "    aspect=20,\n",
    "    fontsize=20,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>approved</th>\n",
       "      <th>combined_max_phase</th>\n",
       "      <th>count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>approved</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>195</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>approved</td>\n",
       "      <td>Phase I</td>\n",
       "      <td>134</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>approved</td>\n",
       "      <td>Phase III</td>\n",
       "      <td>102</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>approved</td>\n",
       "      <td>Launched</td>\n",
       "      <td>636</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>approved</td>\n",
       "      <td>Phase II</td>\n",
       "      <td>218</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   approved combined_max_phase  count\n",
       "0  approved        Preclinical    195\n",
       "1  approved            Phase I    134\n",
       "4  approved          Phase III    102\n",
       "5  approved           Launched    636\n",
       "8  approved           Phase II    218"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "sankey(\n",
    "    left=df2[\"approved\"],\n",
    "    right=df2[\"combined_max_phase\"],\n",
    "    leftWeight=df2[\"count\"],\n",
    "    rightWeight=df2[\"count\"],\n",
    "    aspect=20,\n",
    "    fontsize=20,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df3 = df2[(df2[\"approved\"] == \"approved\")]\n",
    "sankey(\n",
    "    left=df3[\"combined_max_phase\"],\n",
    "    right=df3[\"approved\"],\n",
    "    leftWeight=df3[\"count\"],\n",
    "    rightWeight=df3[\"count\"],\n",
    "    aspect=20,\n",
    "    fontsize=20,\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+------------+------------------+------------------+-----------+-----+\n",
      "|maxClinPhase|          approved|combined_max_phase|hasMeshData|count|\n",
      "+------------+------------------+------------------+-----------+-----+\n",
      "|         4.0|              null|          Launched|        yes|  105|\n",
      "|         4.0|              null|       Preclinical|        yes|  161|\n",
      "|         4.0|              null|           Phase I|        yes|   94|\n",
      "|         3.0|              null|          Launched|        yes|  159|\n",
      "|         0.5|              null|           Phase I|        yes|    2|\n",
      "|         3.0|              null|              null|        yes| 7307|\n",
      "|         1.0|              null|          Launched|        yes|   21|\n",
      "|         2.0|              null|              null|        yes|15232|\n",
      "|         3.0|approvedIndication|          Launched|        yes|    9|\n",
      "|         4.0|approvedIndication|              null|        yes| 3174|\n",
      "|         2.0|              null|         Phase III|        yes|  213|\n",
      "|         0.5|approvedIndication|              null|         no|    1|\n",
      "|         3.0|              null|              null|         no| 5488|\n",
      "|         1.0|approvedIndication|              null|        yes|    1|\n",
      "|         2.0|              null|          Phase II|        yes| 1265|\n",
      "|         4.0|approvedIndication|         Phase III|        yes|  102|\n",
      "|         3.0|approvedIndication|          Phase II|        yes|    1|\n",
      "|         2.0|approvedIndication|          Phase II|        yes|    3|\n",
      "|         0.5|              null|          Phase II|        yes|   14|\n",
      "|         2.0|approvedIndication|              null|        yes|   17|\n",
      "+------------+------------------+------------------+-----------+-----+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").join(\n",
    "    nelson.selectExpr(\n",
    "        \"target as approvedSymbol\",\n",
    "        \"indication_mesh_id as unionMesh\",\n",
    "        \"combined_max_phase\",\n",
    "    ),\n",
    "    on=[\"approvedSymbol\", \"unionMesh\"],\n",
    "    how=\"outer\",\n",
    ").groupBy(\n",
    "    \"maxClinPhase\", \"approved\", \"combined_max_phase\", \"hasMeshData\"\n",
    ").count().show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+------------+------------------+-----+\n",
      "|maxClinPhase|          approved|count|\n",
      "+------------+------------------+-----+\n",
      "|         0.5|approvedIndication|    1|\n",
      "|         0.5|              null| 1285|\n",
      "|         1.0|approvedIndication|   45|\n",
      "|         1.0|              null|13960|\n",
      "|         2.0|approvedIndication|  308|\n",
      "|         2.0|              null|29679|\n",
      "|         3.0|approvedIndication|  466|\n",
      "|         3.0|              null|13725|\n",
      "|         4.0|approvedIndication| 6387|\n",
      "|         4.0|              null|15509|\n",
      "+------------+------------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.groupBy(\"maxClinPhase\", \"approved\").count().sort(\n",
    "    F.col(\"maxClinPhase\").desc()\n",
    ").sort(F.col(\"maxClinPhase\").asc(), F.col(\"approved\").desc()).show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 208:===================>                                     (1 + 2) / 3]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+------------------+----+-----+-----+-----+-----+\n",
      "|          approved| 0.5|  1.0|  2.0|  3.0|  4.0|\n",
      "+------------------+----+-----+-----+-----+-----+\n",
      "|approvedIndication|   1|   45|  308|  466| 6387|\n",
      "|              null|1285|13960|29679|13725|15509|\n",
      "+------------------+----+-----+-----+-----+-----+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indiLabelapproved.groupBy(\"approved\").pivot(\"maxClinPhase\").count().show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+------------------+------------------+-----+\n",
      "|          approved|combined_max_phase|count|\n",
      "+------------------+------------------+-----+\n",
      "|              null|              null|69396|\n",
      "|              null|          Launched|  382|\n",
      "|              null|           Phase I|  751|\n",
      "|              null|       Preclinical|  973|\n",
      "|              null|         Phase III|  595|\n",
      "|              null|          Phase II| 2061|\n",
      "|approvedIndication|       Preclinical|  195|\n",
      "|approvedIndication|              null| 5922|\n",
      "|approvedIndication|          Phase II|  218|\n",
      "|approvedIndication|           Phase I|  134|\n",
      "|approvedIndication|         Phase III|  102|\n",
      "|approvedIndication|          Launched|  636|\n",
      "+------------------+------------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "chemblTD.join(indiLabelapproved, on=[\"targetId\", \"diseaseId\"], how=\"left\").join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").join(\n",
    "    target.selectExpr(\"id as targetId\", \"approvedSymbol\"), on=\"targetId\", how=\"left\"\n",
    ").join(\n",
    "    nelson.withColumn(\"hasNelson\", F.lit(\"hasNelson\")).selectExpr(\n",
    "        \"target as approvedSymbol\",\n",
    "        \"indication_mesh_id as unionMesh\",\n",
    "        \"combined_max_phase\",\n",
    "        \"hasNelson\",\n",
    "    ),\n",
    "    on=[\"approvedSymbol\", \"unionMesh\"],\n",
    "    how=\"left\",\n",
    ").groupBy(\n",
    "    \"approved\", \"combined_max_phase\"\n",
    ").count().sort(\n",
    "    F.col(\"approved\")\n",
    ").show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "chemblTD.join(indiLabel, on=[\"targetId\", \"diseaseId\"], how=\"left\").join(\n",
    "    diseasesWithAnnotations.selectExpr(\"id as diseaseId\", \"unionMesh\", \"hasMeshData\"),\n",
    "    on=\"diseaseId\",\n",
    "    how=\"left\",\n",
    ").join"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "7207"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "indiLabel.count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "#####\n",
    "\n",
    "###\n",
    "\n",
    "#####"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 53:===================>                                      (1 + 2) / 3]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+---------------+\n",
      "|id         |indications                                                                                                                                                                                                                                                                                                                                                                                                                                                            |approvedIndications|indicationCount|\n",
      "+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+---------------+\n",
      "|CHEMBL52885|[{EFO_1001951, colorectal carcinoma, [{ClinicalTrials, [NCT00016250]}], 2.0}, {EFO_0003060, non-small cell lung carcinoma, [{ClinicalTrials, [NCT00408226]}], 1.0}, {EFO_0002618, pancreatic carcinoma, [{ClinicalTrials, [NCT00568646]}], 2.0}, {MONDO_0007254, breast cancer, [{ClinicalTrials, [NCT00306631]}], 2.0}, {MONDO_0004992, cancer, [{ClinicalTrials, [NCT00656461]}], 1.0}, {EFO_0000616, neoplasm, [{ClinicalTrials, [NCT00003755, NCT00014365]}], 1.0}]|[]                 |6              |\n",
      "+-----------+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------+---------------+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indications.filter(F.col(\"Id\") == \"CHEMBL52885\").show(truncate=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+-------------+--------------------+--------------------+---------------------+--------------------+\n",
      "|           id|      disease|             efoName|          references|maxPhaseForIndication| approvedIndications|\n",
      "+-------------+-------------+--------------------+--------------------+---------------------+--------------------+\n",
      "|CHEMBL1200796|MONDO_0019391|      fanconi anemia|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0008498|  clear cell sarcoma|[{ClinicalTrials,...|                  1.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0005952|non-hodgkins lymp...|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0002087|        fibrosarcoma|[{ClinicalTrials,...|                  1.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0001642|   lymphoid neoplasm|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_1001779|chronic myelomono...|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0003032|anaplastic large ...|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0004255|  nephrotic syndrome|[{DailyMed, [0e9e...|                  4.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0003811|refractory anemia...|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|MONDO_0015760|t-cell non-hodgki...|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0006475|plasma cell leukemia|[{ClinicalTrials,...|                  1.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_1000292|      hepatoblastoma|[{ClinicalTrials,...|                  1.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0006861|male breast carci...|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0007147|anogenital venere...|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|MONDO_0008903|         lung cancer|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_1000749|           pemphigus|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|MONDO_0018076|        tuberculosis|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_1000309|juvenile myelomon...|[{ClinicalTrials,...|                  2.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|MONDO_0000873|lymphoblastic lym...|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "|CHEMBL1200796|  EFO_0000502|ganglioneuroblastoma|[{ClinicalTrials,...|                  3.0|[MONDO_0009348, E...|\n",
      "+-------------+-------------+--------------------+--------------------+---------------------+--------------------+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    }
   ],
   "source": [
    "#####\n",
    "indications.select(\n",
    "    \"id\", F.explode_outer(\"indications\").alias(\"indications\"), \"approvedIndications\"\n",
    ").select(\n",
    "    \"id\", \"indications.*\", F.explode_outer(\"approvedIndications\").alias(\"approved\")\n",
    ").show()\n",
    "\n",
    "### Make explosion of the indications and take the maximum clinical phase\n",
    "###"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+-------------------+------------------+\n",
      "|           id|approvedIndications|launchedIndication|\n",
      "+-------------+-------------------+------------------+\n",
      "|CHEMBL1200796|      MONDO_0009348|          launched|\n",
      "|CHEMBL1200796|        EFO_0000616|          launched|\n",
      "|CHEMBL1200796|        EFO_0003869|          launched|\n",
      "|CHEMBL1200796|        EFO_1000294|          launched|\n",
      "|CHEMBL1200796|        EFO_0004255|          launched|\n",
      "|CHEMBL1200796|        EFO_0000574|          launched|\n",
      "|CHEMBL1200796|      MONDO_0004992|          launched|\n",
      "|CHEMBL1200796|      MONDO_0007254|          launched|\n",
      "|CHEMBL1200796|        EFO_0001378|          launched|\n",
      "|CHEMBL1200796|        EFO_0000183|          launched|\n",
      "|CHEMBL1200796|        EFO_0000305|          launched|\n",
      "|CHEMBL1201581|        EFO_0000729|          launched|\n",
      "|CHEMBL1201581|        EFO_0000685|          launched|\n",
      "|CHEMBL1201581|        EFO_0003898|          launched|\n",
      "|CHEMBL1201581|        EFO_0000676|          launched|\n",
      "|CHEMBL1201581|        EFO_0003778|          launched|\n",
      "|CHEMBL1201581|        EFO_0000540|          launched|\n",
      "|CHEMBL1201581|        EFO_0000384|          launched|\n",
      "|    CHEMBL135|        EFO_1001271|          launched|\n",
      "|    CHEMBL135|        EFO_0003869|          launched|\n",
      "+-------------+-------------------+------------------+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "indications.select(\n",
    "    \"id\", F.explode_outer(\"approvedIndications\").alias(\"approvedIndications\")\n",
    ").select(\"id\", \"approvedIndications\").withColumn(\n",
    "    \"launchedIndication\", F.lit(\"launched\")\n",
    ").show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Count N of T-I with Maximum clinical trials different between ChEMBL evidences and Pharmaprojects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+----------+\n",
      "|   differences|sum(count)|\n",
      "+--------------+----------+\n",
      "|         equal|      1835|\n",
      "|Nelson<<Chembl|      1912|\n",
      "|Nelson>>Chembl|       701|\n",
      "+--------------+----------+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(\n",
    "    F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()\n",
    ").groupBy(\n",
    "    \"combinedPhase\", \"maxClinPhase\"\n",
    ").count().withColumn(\n",
    "    \"differences\",\n",
    "    F.when(F.col(\"combinedPhase\") == F.col(\"maxClinPhase\"), F.lit(\"equal\"))\n",
    "    .when(F.col(\"combinedPhase\") > F.col(\"maxClinPhase\"), F.lit(\"Nelson>>Chembl\"))\n",
    "    .when(F.col(\"combinedPhase\") < F.col(\"maxClinPhase\"), F.lit(\"Nelson<<Chembl\")),\n",
    ").sort(\n",
    "    F.col(\"differences\").desc()\n",
    ").groupBy(\n",
    "    \"differences\"\n",
    ").agg(\n",
    "    F.sum(F.col(\"count\"))\n",
    ").show(\n",
    "    100\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### See changes between clinical phases between datasets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+------------+-----+--------------+\n",
      "|combinedPhase|maxClinPhase|count|   differences|\n",
      "+-------------+------------+-----+--------------+\n",
      "|          0.5|         4.0|  309|Nelson<<Chembl|\n",
      "|          0.5|         3.0|  136|Nelson<<Chembl|\n",
      "|          0.5|         2.0|  257|Nelson<<Chembl|\n",
      "|          0.5|         1.0|  164|Nelson<<Chembl|\n",
      "|          1.0|         0.5|    1|Nelson>>Chembl|\n",
      "|          1.0|         4.0|  189|Nelson<<Chembl|\n",
      "|          1.0|         2.0|  192|Nelson<<Chembl|\n",
      "|          1.0|         3.0|   59|Nelson<<Chembl|\n",
      "|          2.0|         4.0|  301|Nelson<<Chembl|\n",
      "|          2.0|         1.0|  320|Nelson>>Chembl|\n",
      "|          2.0|         3.0|  173|Nelson<<Chembl|\n",
      "|          2.0|         0.5|    7|Nelson>>Chembl|\n",
      "|          3.0|         1.0|   32|Nelson>>Chembl|\n",
      "|          3.0|         0.5|    1|Nelson>>Chembl|\n",
      "|          3.0|         2.0|  145|Nelson>>Chembl|\n",
      "|          3.0|         4.0|  132|Nelson<<Chembl|\n",
      "|          4.0|         2.0|   74|Nelson>>Chembl|\n",
      "|          4.0|         3.0|  108|Nelson>>Chembl|\n",
      "|          4.0|         1.0|   13|Nelson>>Chembl|\n",
      "+-------------+------------+-----+--------------+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(\n",
    "    F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()\n",
    ").groupBy(\n",
    "    \"combinedPhase\", \"maxClinPhase\"\n",
    ").count().withColumn(\n",
    "    \"differences\",\n",
    "    F.when(F.col(\"combinedPhase\") == F.col(\"maxClinPhase\"), F.lit(\"equal\"))\n",
    "    .when(F.col(\"combinedPhase\") > F.col(\"maxClinPhase\"), F.lit(\"Nelson>>Chembl\"))\n",
    "    .when(F.col(\"combinedPhase\") < F.col(\"maxClinPhase\"), F.lit(\"Nelson<<Chembl\")),\n",
    ").filter(\n",
    "    F.col(\"differences\") != \"equal\"\n",
    ").sort(\n",
    "    F.col(\"combinedPhase\").asc()\n",
    ").show(\n",
    "    100\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Print diseases from T-D where Pharmaprojects is preclinical and ChEMBL appears approved"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 435:>                                                        (0 + 1) / 1]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+----------------------------------------+-----+\n",
      "|label                                   |count|\n",
      "+----------------------------------------+-----+\n",
      "|immune system disease                   |36   |\n",
      "|neoplasm                                |30   |\n",
      "|cardiovascular disease                  |25   |\n",
      "|diabetes mellitus                       |12   |\n",
      "|obesity                                 |10   |\n",
      "|epilepsy                                |10   |\n",
      "|post-traumatic stress disorder          |8    |\n",
      "|atherosclerosis                         |8    |\n",
      "|inflammatory bowel disease              |5    |\n",
      "|heart failure                           |5    |\n",
      "|mental or behavioural disorder          |5    |\n",
      "|chronic obstructive pulmonary disease   |5    |\n",
      "|myocardial infarction                   |4    |\n",
      "|insomnia                                |4    |\n",
      "|Hepatitis, Alcoholic                    |4    |\n",
      "|atrial fibrillation                     |4    |\n",
      "|blood coagulation disease               |4    |\n",
      "|non-small cell lung carcinoma           |3    |\n",
      "|neuralgia                               |3    |\n",
      "|hypertension                            |3    |\n",
      "|lymphoma                                |3    |\n",
      "|skin disease                            |3    |\n",
      "|opioid dependence                       |3    |\n",
      "|age-related macular degeneration        |3    |\n",
      "|cardiac arrhythmia                      |3    |\n",
      "|systemic scleroderma                    |3    |\n",
      "|attention deficit hyperactivity disorder|3    |\n",
      "|Crohn's disease                         |3    |\n",
      "|drug dependence                         |3    |\n",
      "|male infertility                        |2    |\n",
      "|endometriosis                           |2    |\n",
      "|stroke                                  |2    |\n",
      "|malaria                                 |2    |\n",
      "|rheumatoid arthritis                    |2    |\n",
      "|autism                                  |2    |\n",
      "|actinic keratosis                       |2    |\n",
      "|ankylosing spondylitis                  |2    |\n",
      "|gout                                    |2    |\n",
      "|social anxiety disorder                 |2    |\n",
      "|kidney failure                          |2    |\n",
      "|psoriasis                               |2    |\n",
      "|arthritis                               |2    |\n",
      "|acute coronary syndrome                 |2    |\n",
      "|Sjogren syndrome                        |2    |\n",
      "|complex regional pain syndrome          |2    |\n",
      "|obsessive-compulsive disorder           |2    |\n",
      "|Cutaneous T-cell lymphoma               |2    |\n",
      "|angina pectoris                         |2    |\n",
      "|erectile dysfunction                    |2    |\n",
      "|macular degeneration                    |2    |\n",
      "|anemia (phenotype)                      |2    |\n",
      "|chronic kidney disease                  |2    |\n",
      "|irritable bowel syndrome                |2    |\n",
      "|colorectal neoplasm                     |2    |\n",
      "|diabetic retinopathy                    |1    |\n",
      "|ulcerative colitis                      |1    |\n",
      "|poisoning                               |1    |\n",
      "|colitis                                 |1    |\n",
      "|multiple myeloma                        |1    |\n",
      "|conjunctivitis                          |1    |\n",
      "|retinal detachment                      |1    |\n",
      "|dry eye syndrome                        |1    |\n",
      "|retinopathy                             |1    |\n",
      "|unipolar depression                     |1    |\n",
      "|peripheral nervous system disease       |1    |\n",
      "|partial epilepsy                        |1    |\n",
      "|diabetic nephropathy                    |1    |\n",
      "|idiopathic pulmonary fibrosis           |1    |\n",
      "|polycystic ovary syndrome               |1    |\n",
      "|emphysema                               |1    |\n",
      "|gastric ulcer                           |1    |\n",
      "|gastroesophageal reflux disease         |1    |\n",
      "|bone fracture                           |1    |\n",
      "|juvenile idiopathic arthritis           |1    |\n",
      "|pneumonia                               |1    |\n",
      "|metabolic disease                       |1    |\n",
      "|small cell lung carcinoma               |1    |\n",
      "|diffuse large B-cell lymphoma           |1    |\n",
      "|benign prostatic hyperplasia            |1    |\n",
      "|non-Hodgkins lymphoma                   |1    |\n",
      "|metabolic syndrome                      |1    |\n",
      "|kidney disease                          |1    |\n",
      "|seborrheic dermatitis                   |1    |\n",
      "|endocrine system disease                |1    |\n",
      "|contact dermatitis                      |1    |\n",
      "|lupus nephritis                         |1    |\n",
      "|freckles                                |1    |\n",
      "|brain neoplasm                          |1    |\n",
      "|infection                               |1    |\n",
      "|cardiomyopathy                          |1    |\n",
      "|hepatitis C virus infection             |1    |\n",
      "|non-alcoholic fatty liver disease       |1    |\n",
      "|viral disease                           |1    |\n",
      "|retinal vein occlusion                  |1    |\n",
      "|rhinitis                                |1    |\n",
      "|breast neoplasm                         |1    |\n",
      "|wet macular degeneration                |1    |\n",
      "|female infertility                      |1    |\n",
      "+----------------------------------------+-----+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 0.5) & (F.col(\"maxClinPhase\") == 4.0)\n",
    ").groupBy(\n",
    "    \"label\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Print genes from T-D where Pharmaprojects is preclinical and ChEMBL appears approved"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+-----+\n",
      "|approvedSymbol|count|\n",
      "+--------------+-----+\n",
      "|NR3C1         |11   |\n",
      "|PTGS2         |8    |\n",
      "|PTGS1         |6    |\n",
      "|CNR1          |5    |\n",
      "|ESR1          |5    |\n",
      "|PGF           |5    |\n",
      "|ACE           |4    |\n",
      "|GRIN1         |4    |\n",
      "|OPRM1         |4    |\n",
      "|PPARG         |4    |\n",
      "|ADORA2B       |4    |\n",
      "|HMGCR         |4    |\n",
      "|VEGFA         |3    |\n",
      "|ADRA2A        |3    |\n",
      "|OPRD1         |3    |\n",
      "|AGTR1         |3    |\n",
      "|VDR           |3    |\n",
      "|PDE3A         |3    |\n",
      "|ADORA3        |3    |\n",
      "|HRH1          |3    |\n",
      "|TRPV1         |3    |\n",
      "|SLC5A2        |3    |\n",
      "|RXRG          |2    |\n",
      "|GABRA4        |2    |\n",
      "|FKBP1A        |2    |\n",
      "|SLC6A4        |2    |\n",
      "|PGR           |2    |\n",
      "|CRBN          |2    |\n",
      "|SCN5A         |2    |\n",
      "|MT-ND1        |2    |\n",
      "|HTR3A         |2    |\n",
      "|PDE10A        |2    |\n",
      "|ABAT          |2    |\n",
      "|TUBB          |2    |\n",
      "|SCN1A         |2    |\n",
      "|TNF           |2    |\n",
      "|TNFSF13B      |2    |\n",
      "|IFNG          |2    |\n",
      "|PDE4A         |2    |\n",
      "|MS4A1         |2    |\n",
      "|AR            |2    |\n",
      "|ITGB7         |2    |\n",
      "|HTR1F         |2    |\n",
      "|IL17A         |2    |\n",
      "|PDE4D         |2    |\n",
      "|TLR7          |2    |\n",
      "|CHRM3         |2    |\n",
      "|ADA           |2    |\n",
      "|SLC6A2        |2    |\n",
      "|XDH           |2    |\n",
      "|CHRM1         |2    |\n",
      "|C5AR1         |2    |\n",
      "|CACNA1C       |2    |\n",
      "|C5            |2    |\n",
      "|RXRA          |2    |\n",
      "|SCN9A         |2    |\n",
      "|ADORA2A       |2    |\n",
      "|CD2           |2    |\n",
      "|ITGA4         |2    |\n",
      "|RXRB          |2    |\n",
      "|GABRA1        |2    |\n",
      "|S1PR3         |2    |\n",
      "|GABRD         |2    |\n",
      "|TUBB3         |2    |\n",
      "|HTR2C         |2    |\n",
      "|KCNJ8         |1    |\n",
      "|KCNK9         |1    |\n",
      "|C3            |1    |\n",
      "|HTR1A         |1    |\n",
      "|CHRNA4        |1    |\n",
      "|CD86          |1    |\n",
      "|CD3E          |1    |\n",
      "|CCR5          |1    |\n",
      "|DDR2          |1    |\n",
      "|NPM1          |1    |\n",
      "|DRD1          |1    |\n",
      "|IL1B          |1    |\n",
      "|TNFRSF17      |1    |\n",
      "|FSHR          |1    |\n",
      "|PLG           |1    |\n",
      "|GABBR1        |1    |\n",
      "|IFNGR1        |1    |\n",
      "|SSTR2         |1    |\n",
      "|ANGPTL3       |1    |\n",
      "|IL6           |1    |\n",
      "|FGB           |1    |\n",
      "|KIT           |1    |\n",
      "|GLP1R         |1    |\n",
      "|IL23A         |1    |\n",
      "|ATP1A1        |1    |\n",
      "|P4HTM         |1    |\n",
      "|TTR           |1    |\n",
      "|HTR2A         |1    |\n",
      "|ABCC9         |1    |\n",
      "|GABRA3        |1    |\n",
      "|FGA           |1    |\n",
      "|SCN10A        |1    |\n",
      "|IL11RA        |1    |\n",
      "|PPARA         |1    |\n",
      "|F2            |1    |\n",
      "|TYK2          |1    |\n",
      "|LHCGR         |1    |\n",
      "|GIPR          |1    |\n",
      "|PRKCI         |1    |\n",
      "|IL1RAP        |1    |\n",
      "|DRD2          |1    |\n",
      "|PRKD1         |1    |\n",
      "|EDNRA         |1    |\n",
      "|CYP17A1       |1    |\n",
      "|ACHE          |1    |\n",
      "|TNNC1         |1    |\n",
      "|SLC6A1        |1    |\n",
      "|DNMT1         |1    |\n",
      "|PDE8B         |1    |\n",
      "|SLC6A3        |1    |\n",
      "|IFNAR2        |1    |\n",
      "|GAA           |1    |\n",
      "|ACLY          |1    |\n",
      "|KCNQ4         |1    |\n",
      "|JAK1          |1    |\n",
      "|SERPINC1      |1    |\n",
      "|SSTR4         |1    |\n",
      "|PRKCG         |1    |\n",
      "|CACNA1D       |1    |\n",
      "|PDGFRA        |1    |\n",
      "|JAK2          |1    |\n",
      "|ADRB1         |1    |\n",
      "|GART          |1    |\n",
      "|HDAC8         |1    |\n",
      "|MTOR          |1    |\n",
      "|ESR2          |1    |\n",
      "|ELANE         |1    |\n",
      "|ADRA2B        |1    |\n",
      "|GRIN2D        |1    |\n",
      "|ITGA2B        |1    |\n",
      "|SIGMAR1       |1    |\n",
      "|ADRB2         |1    |\n",
      "|PPIA          |1    |\n",
      "|PDE4B         |1    |\n",
      "|EPHA3         |1    |\n",
      "|HTR1B         |1    |\n",
      "|C1S           |1    |\n",
      "|KCNA5         |1    |\n",
      "|OPRK1         |1    |\n",
      "|CA2           |1    |\n",
      "|CALCB         |1    |\n",
      "|PDGFRB        |1    |\n",
      "|TOP2A         |1    |\n",
      "|ADORA1        |1    |\n",
      "|KCNJ11        |1    |\n",
      "|NR1H4         |1    |\n",
      "|GABRA2        |1    |\n",
      "|DHFR          |1    |\n",
      "|NPC1L1        |1    |\n",
      "|IL6R          |1    |\n",
      "|MTNR1B        |1    |\n",
      "|SCN2A         |1    |\n",
      "|MIF           |1    |\n",
      "|TLR9          |1    |\n",
      "|PRKCZ         |1    |\n",
      "|GABRA5        |1    |\n",
      "|PCSK9         |1    |\n",
      "|HTR5A         |1    |\n",
      "|ITGB3         |1    |\n",
      "|SLAMF7        |1    |\n",
      "|ROCK2         |1    |\n",
      "|PTK6          |1    |\n",
      "|SCN3A         |1    |\n",
      "|CALCA         |1    |\n",
      "|NTRK1         |1    |\n",
      "|NPR1          |1    |\n",
      "|PTGIR         |1    |\n",
      "|GRIN2B        |1    |\n",
      "|CD79B         |1    |\n",
      "|OXTR          |1    |\n",
      "|LCK           |1    |\n",
      "|HBB           |1    |\n",
      "|IL12B         |1    |\n",
      "|CHRM2         |1    |\n",
      "|PMEL          |1    |\n",
      "|MAPK11        |1    |\n",
      "|PDE4C         |1    |\n",
      "|KDR           |1    |\n",
      "|FGG           |1    |\n",
      "|EPOR          |1    |\n",
      "|IFNAR1        |1    |\n",
      "|EPHB3         |1    |\n",
      "|MTNR1A        |1    |\n",
      "|EPHA1         |1    |\n",
      "|IL3RA         |1    |\n",
      "|HDAC3         |1    |\n",
      "|SLC10A1       |1    |\n",
      "|JAK3          |1    |\n",
      "|HRH2          |1    |\n",
      "+--------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 0.5) & (F.col(\"maxClinPhase\") == 4.0)\n",
    ").groupBy(\n",
    "    \"approvedSymbol\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### See cases where Pharmaprojects is phaseIV (launched) and ChEMBL below it."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+-----------+------------------+---------------+---------------------------------+--------------------------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+-------------------------------------------+------------+--------------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+----------+------------+--------+-------------+---------+--------+-----------+----------+-----------+----------+-----------+------------------------------------------------------+---------------+----------------------------+------------+------------+-----------+----------------+------+-----------+------+-------------------------------------+-----------+---------------+------------+-------------+\n",
      "|approvedSymbol|diseaseId  |indication_mesh_id|ti_uid         |indication_association_similarity|indication_mesh_term                  |historical_max_phase|active_max_phase|combined_max_phase|succ_p_1|succ_1_2|succ_2_3|succ_3_a|orphan|year_launch|assoc_mesh_id|assoc_mesh_term                            |assoc_source|assoc_info                                  |original_trait                                                                                            |original_link                                                                                                                        |assoc_year|pic_qtl_pval|pic_h4  |af_gnomad_nfe|l2g_share|l2g_rank|assoc_share|assoc_rank|source_name|abs_beta  |abs_or     |areas                                                 |genetic_insight|target_status               |ab_tractable|sm_tractable|rhodop_gpcr|nuclear_receptor|enzyme|ion_channel|kinase|label                                |efo_column |targetId       |maxClinPhase|combinedPhase|\n",
      "+--------------+-----------+------------------+---------------+---------------------------------+--------------------------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+-------------------------------------------+------------+--------------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+----------+------------+--------+-------------+---------+--------+-----------+----------+-----------+----------+-----------+------------------------------------------------------+---------------+----------------------------+------------+------------+-----------+----------------+------+-----------+------+-------------------------------------+-----------+---------------+------------+-------------+\n",
      "|FGFR2         |EFO_1001513|D008113           |FGFR2-D008113  |0.671                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (gamma-glutamyl transferase)                                                          |https://genetics.opentargets.org/study/GCST90013407                                                                                  |2021      |null        |null    |0.564816019  |0.92     |1       |0.92       |1         |GWAS       |0.00439844|null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000066468|2.0         |4.0          |\n",
      "|IL6           |EFO_0000685|D001172           |IL6-D001172    |0.413                            |Arthritis, Rheumatoid                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D001249      |Asthma                                     |OTG         |null                                        |Asthma (childhood onset)                                                                                  |https://genetics.opentargets.org/study/GCST007800                                                                                    |2019      |null        |null    |0.29319542   |0.52     |1       |0.52       |1         |GWAS       |null      |null       |musculoskeletal, dermatology, immune                  |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |rheumatoid arthritis                 |EFO_0000685|ENSG00000136244|3.0         |4.0          |\n",
      "|CNR1          |EFO_0003768|D014029           |CNR1-D014029   |0.014                            |Tobacco Use Disorder                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2016       |D000069196   |Gastrointestinal Microbiome                |OTG         |null                                        |Gut microbiota (functional units) [PWY-5345_superpathway_of_L-methionine_biosynthesis_(by_sulfhydrylation]|https://genetics.opentargets.org/study/GCST003854_29                                                                                 |2016      |null        |null    |0.192327665  |0.9      |1       |0.9        |1         |GWAS       |5.4949656 |null       |psychiatry                                            |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |nicotine dependence                  |EFO_0003768|ENSG00000118432|2.0         |4.0          |\n",
      "|CSF1R         |EFO_0002430|D055728           |CSF1R-D055728  |0.476                            |Primary Myelofibrosis                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Granulocyte percentage of myeloid white cells                                                             |https://genetics.opentargets.org/study/GCST004608                                                                                    |2016      |null        |null    |0.633411581  |0.58     |1       |0.58       |1         |GWAS       |0.03435342|null       |hematology                                            |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |primary myelofibrosis                |EFO_0002430|ENSG00000182578|1.0         |4.0          |\n",
      "|FLT4          |EFO_0004230|D016889           |FLT4-D016889   |0.514                            |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000037280|3.0         |4.0          |\n",
      "|FGFR3         |EFO_0003865|D007680           |FGFR3-D007680  |0.874                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001749      |Urinary Bladder Neoplasms                  |PICCOLO     |gtex-v6p-adipose-subcutaneous               |bladder_cancer                                                                                            |https://www.ncbi.nlm.nih.gov/pubmed/20972438                                                                                         |2010      |6.04E-15    |0.912895|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000068078|2.0         |4.0          |\n",
      "|CD276         |EFO_0000621|D009447           |CD276-D009447  |0.231                            |Neuroblastoma                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Sex hormone-binding globulin levels adjusted for BMI                                                      |https://genetics.opentargets.org/study/GCST90012108                                                                                  |2020      |null        |null    |0.398595944  |0.8      |1       |0.8        |1         |GWAS       |0.00660829|null       |oncology                                              |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |neuroblastoma                        |EFO_0000621|ENSG00000103855|2.0         |4.0          |\n",
      "|AR            |EFO_0000284|D011470           |AR-D011470     |0.372                            |Prostatic Hyperplasia                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Malignant neoplasm of prostate                                                                            |https://genetics.opentargets.org/study/FINNGEN_R6_C3_PROSTATE                                                                        |2022      |null        |null    |0.001936733  |0.77     |1       |0.77       |1         |GWAS       |null      |1.33530536 |other                                                 |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |benign prostatic hyperplasia         |EFO_0000284|ENSG00000169083|2.0         |4.0          |\n",
      "|FGFR4         |EFO_0003060|D002289           |FGFR4-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.307667316  |0.69     |1       |0.69       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000160867|3.0         |4.0          |\n",
      "|ERBB4         |EFO_0003869|D001943           |ERBB4-D001943  |1                                |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D001943      |Breast Neoplasms                           |OTG         |null                                        |Breast cancer                                                                                             |https://genetics.opentargets.org/study/GCST001457                                                                                    |2012      |null        |null    |0.088945115  |1        |1       |1          |1         |GWAS       |null      |1.53       |oncology                                              |both           |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |breast neoplasm                      |EFO_0003869|ENSG00000178568|3.0         |4.0          |\n",
      "|CD19          |EFO_0005952|D008228           |CD19-D008228   |0.365                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D017074      |Common Variable Immunodeficiency           |OMIM        |null                                        |Immunodeficiency, common variable, 3, 613493 (3), Autosomal recessive                                     |https://omim.org/entry/107265                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000177455|3.0         |4.0          |\n",
      "|FGFR2         |EFO_0003060|D002289           |FGFR2-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.566796621  |0.81     |1       |0.81       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000066468|3.0         |4.0          |\n",
      "|FGFR1         |EFO_1001513|D008113           |FGFR1-D008113  |0.671                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (alanine transaminase)                                                                |https://genetics.opentargets.org/study/GCST90013405                                                                                  |2021      |null        |null    |0.413416537  |0.81     |1       |0.81       |1         |GWAS       |0.00219045|null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000077782|2.0         |4.0          |\n",
      "|CYP11B2       |EFO_1001110|D047748           |CYP11B2-D047748|0.453                            |Pituitary ACTH Hypersecretion         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006994      |Hypoaldosteronism                          |OMIM        |null                                        |Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3), Autosomal recessive                   |https://omim.org/entry/124080                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |neurology, endocrine                                  |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pituitary-dependent Cushing's disease|EFO_1001110|ENSG00000179142|3.0         |4.0          |\n",
      "|BTK           |EFO_0005952|D008228           |BTK-D008228    |0.261                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000010671|3.0         |4.0          |\n",
      "|FKBP1A        |EFO_1000906|D015352           |FKBP1A-D015352 |0.03                             |Dry Eye Syndromes                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D005919      |Glomerular Filtration Rate                 |OTG         |null                                        |Estimated glomerular filtration rate in non-diabetics                                                     |https://genetics.opentargets.org/study/GCST008745                                                                                    |2019      |null        |null    |0.067878001  |0.52     |1       |0.52       |1         |GWAS       |0.605     |null       |ophthalmology                                         |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |dry eye syndrome                     |EFO_1000906|ENSG00000088832|2.0         |4.0          |\n",
      "|FGFR3         |EFO_0009001|D008415           |FGFR3-D008415  |0.491                            |Mastocytosis                          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D000505      |Alopecia                                   |OTG         |null                                        |Male-pattern baldness                                                                                     |https://genetics.opentargets.org/study/GCST007020                                                                                    |2018      |null        |null    |0.296383034  |0.66     |1       |0.66       |1         |GWAS       |0.0201814 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Mastocytosis                         |EFO_0009001|ENSG00000068078|2.0         |4.0          |\n",
      "|FGFR1         |EFO_0003860|D010190           |FGFR1-D010190  |0.599                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |pancreatic neoplasm                  |EFO_0003860|ENSG00000077782|2.0         |4.0          |\n",
      "|FLT1          |EFO_0003865|D007680           |FLT1-D007680   |0.511                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011225      |Pre-Eclampsia                              |OTG         |null                                        |Preeclampsia (fetal genotype effect)                                                                      |https://genetics.opentargets.org/study/GCST90013475                                                                                  |2020      |null        |null    |0.498830257  |0.62     |1       |0.62       |1         |GWAS       |null      |1.19       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000102755|3.0         |4.0          |\n",
      "|CD274         |EFO_0000183|D006689           |CD274-D006689  |0.203                            |Hodgkin Disease                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Hodgkins lymphoma                    |EFO_0000183|ENSG00000120217|2.0         |4.0          |\n",
      "|LYN           |EFO_0000768|D054990           |LYN-D054990    |0.229                            |Idiopathic Pulmonary Fibrosis         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2015       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Sum neutrophil eosinophil counts                                                                          |https://genetics.opentargets.org/study/GCST004613                                                                                    |2016      |null        |null    |0.68223205   |0.85     |1       |0.85       |1         |GWAS       |0.02448989|null       |respiratory                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |idiopathic pulmonary fibrosis        |EFO_0000768|ENSG00000254087|1.0         |4.0          |\n",
      "|PDCD1         |EFO_0004252|D009303           |PDCD1-D009303  |0                                |Nasopharyngeal Neoplasms              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |nasopharyngeal neoplasm              |EFO_0004252|ENSG00000188389|3.0         |4.0          |\n",
      "|PLAT          |EFO_0000319|D002318           |PLAT-D002318   |0.243                            |Cardiovascular Diseases               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D017496      |Hypopigmentation                           |OTG         |null                                        |Skin colour                                                                                               |https://genetics.opentargets.org/study/NEALE2_1717                                                                                   |2018      |null        |null    |0.572023422  |0.5      |1       |0.5        |1         |GWAS       |0.00777909|null       |cardiovascular                                        |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |cardiovascular disease               |EFO_0000319|ENSG00000104368|3.0         |4.0          |\n",
      "|BRAF          |EFO_0003060|D002289           |BRAF-D002289   |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FVC)                                                                                       |https://genetics.opentargets.org/study/GCST007081                                                                                    |2018      |null        |null    |0.536907083  |0.78     |1       |0.78       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000157764|3.0         |4.0          |\n",
      "|APOC3         |EFO_1000727|D008060           |APOC3-D008060  |0.733                            |Lipodystrophy                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006937      |Hypercholesterolemia                       |OTG         |null                                        |Total cholesterol levels                                                                                  |https://genetics.opentargets.org/study/GCST90025953                                                                                  |2021      |null        |null    |0.612917913  |0.66     |1       |0.66       |1         |GWAS       |0.0334341 |null       |dermatology, metabolic                                |omim/tcga      |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |lipodystrophy                        |EFO_1000727|ENSG00000110245|2.0         |4.0          |\n",
      "|FGFR3         |EFO_0000702|D055752           |FGFR3-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.066878568  |0.8      |1       |0.8        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000068078|2.0         |4.0          |\n",
      "|FLT1          |EFO_0003060|D002289           |FLT1-D002289   |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.921475814  |0.89     |1       |0.89       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000102755|3.0         |4.0          |\n",
      "|IL4R          |EFO_0007486|D012852           |IL4R-D012852   |0.612                            |Sinusitis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D012140      |Respiratory Tract Diseases                 |OTG         |null                                        |Chronic lower respiratory diseases                                                                        |https://genetics.opentargets.org/study/FINNGEN_R6_J10_LOWCHRON                                                                       |2022      |null        |null    |0.007192846  |0.81     |1       |0.81       |1         |GWAS       |null      |1.11478326 |infection, respiratory                                |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |sinusitis                            |EFO_0007486|ENSG00000077238|3.0         |4.0          |\n",
      "|SCN5A         |EFO_0004287|D014693           |SCN5A-D014693  |1                                |Ventricular Fibrillation              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2009       |D014693      |Ventricular Fibrillation                   |OMIM        |null                                        |Ventricular fibrillation, familial, 1, 603829 (3)                                                         |https://omim.org/entry/600163                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |cardiovascular, signs/symptoms                        |omim/tcga      |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |ventricular fibrillation             |EFO_0004287|ENSG00000183873|3.0         |4.0          |\n",
      "|IL17F         |EFO_0003898|D013167           |IL17F-D013167  |0.198                            |Spondylitis, Ankylosing               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001791      |Blood Platelet Disorders                   |OTG         |null                                        |Mean platelet volume                                                                                      |https://genetics.opentargets.org/study/GCST004599                                                                                    |2016      |null        |null    |0.062294651  |0.58     |1       |0.58       |1         |GWAS       |0.04578266|null       |musculoskeletal                                       |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ankylosing spondylitis               |EFO_0003898|ENSG00000112116|3.0         |4.0          |\n",
      "|VEGFA         |EFO_0003865|D007680           |VEGFA-D007680  |0.79                             |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Prostate cancer                                                                                           |https://genetics.opentargets.org/study/GCST011049                                                                                    |2021      |null        |null    |0.501558644  |0.7      |1       |0.7        |1         |GWAS       |null      |1.039      |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000112715|2.0         |4.0          |\n",
      "|MAP2K1        |EFO_0004142|D015179           |MAP2K1-D015179 |0.455                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D009373      |Neoplasms, Germ Cell and Embryonal         |PICCOLO     |CD4-meta-cis                                |testicular_germ_cell_tumor                                                                                |https://www.ncbi.nlm.nih.gov/pubmed/28604728                                                                                         |2017      |2.72E-20    |0.907482|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |colorectal neoplasm                  |EFO_0004142|ENSG00000169032|2.0         |4.0          |\n",
      "|VEGFA         |EFO_0002939|D008527           |VEGFA-D008527  |0.39                             |Medulloblastoma                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Prostate cancer                                                                                           |https://genetics.opentargets.org/study/GCST011049                                                                                    |2021      |null        |null    |0.501558644  |0.7      |1       |0.7        |1         |GWAS       |null      |1.039      |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |medulloblastoma                      |EFO_0002939|ENSG00000112715|2.0         |4.0          |\n",
      "|TOP2A         |EFO_0000621|D009447           |TOP2A-D009447  |0                                |Neuroblastoma                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |neuroblastoma                        |EFO_0000621|ENSG00000131747|3.0         |4.0          |\n",
      "|NR1H4         |EFO_0003095|D065626           |NR1H4-D065626  |0.601                            |Non-alcoholic Fatty Liver Disease     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (gamma-glutamyl transferase)                                                          |https://genetics.opentargets.org/study/GCST90013407                                                                                  |2021      |null        |null    |0.064954486  |0.85     |1       |0.85       |1         |GWAS       |0.00768656|null       |digestive                                             |both           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |non-alcoholic fatty liver disease    |EFO_0003095|ENSG00000012504|3.0         |4.0          |\n",
      "|KIT           |EFO_0003893|D010051           |KIT-D010051    |0.528                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000157404|2.0         |4.0          |\n",
      "|IL17RA        |EFO_0003778|D015535           |IL17RA-D015535 |0.409                            |Arthritis, Psoriatic                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2016       |D002178      |Candidiasis, Chronic Mucocutaneous         |OMIM        |null                                        |Immunodeficiency 51, 613953 (3), Autosomal recessive                                                      |https://omim.org/entry/605461                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |musculoskeletal, dermatology                          |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |psoriatic arthritis                  |EFO_0003778|ENSG00000177663|3.0         |4.0          |\n",
      "|FGFR3         |EFO_0003893|D010051           |FGFR3-D010051  |0.769                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001749      |Urinary Bladder Neoplasms                  |PICCOLO     |gtex-v6p-adipose-subcutaneous               |bladder_cancer                                                                                            |https://www.ncbi.nlm.nih.gov/pubmed/20972438                                                                                         |2010      |6.04E-15    |0.912895|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000068078|2.0         |4.0          |\n",
      "|GNRHR         |EFO_0003869|D001943           |GNRHR-D001943  |0.2                              |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007006      |Hypogonadism                               |OMIM        |null                                        |Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3), Autosomal recessive                          |https://omim.org/entry/138850                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000109163|3.0         |4.0          |\n",
      "|SCN1A         |EFO_0008526|D013226           |SCN1A-D013226  |0.758                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D003294      |Seizures, Febrile                          |OTG         |null                                        |Febrile seizures [Overall]                                                                                |https://genetics.opentargets.org/study/GCST002672_2                                                                                  |2014      |null        |null    |0.68772846   |0.71     |1       |0.71       |1         |GWAS       |null      |1.34       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000144285|3.0         |4.0          |\n",
      "|RET           |EFO_0002429|D011087           |RET-D011087    |0.548                            |Polycythemia Vera                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |polycythemia vera                    |EFO_0002429|ENSG00000165731|2.0         |4.0          |\n",
      "|TOP2A         |EFO_0000095|D015451           |TOP2A-D015451  |0                                |Leukemia, Lymphocytic, Chronic, B-Cell|Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |chronic lymphocytic leukemia         |EFO_0000095|ENSG00000131747|3.0         |4.0          |\n",
      "|TYMS          |EFO_0003860|D010190           |TYMS-D010190   |0.599                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Sex hormone-binding globulin levels                                                                       |https://genetics.opentargets.org/study/GCST90012109                                                                                  |2020      |null        |null    |0.265145606  |0.64     |1       |0.64       |1         |GWAS       |0.00815923|null       |oncology                                              |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000176890|3.0         |4.0          |\n",
      "|IL2RA         |EFO_0000699|D012859           |IL2RA-D012859  |0.803                            |Sjogren's Syndrome                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001172      |Arthritis, Rheumatoid                      |OTG         |null                                        |Rheumatoid arthritis                                                                                      |https://genetics.opentargets.org/study/GCST002318                                                                                    |2013      |null        |null    |0.423422836  |0.85     |1       |0.85       |1         |GWAS       |null      |1.1        |musculoskeletal, ophthalmology, dermatology, immune   |both           |genetically supported target|TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Sjogren syndrome                     |EFO_0000699|ENSG00000134460|1.0         |4.0          |\n",
      "|OPRD1         |EFO_0000555|D043183           |OPRD1-D043183  |0.498                            |Irritable Bowel Syndrome              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D005764      |Gastroesophageal Reflux                    |OTG         |null                                        |Gastroesophageal reflux disease                                                                           |https://genetics.opentargets.org/study/GCST90000514                                                                                  |2021      |null        |null    |0.12665886   |0.83     |1       |0.83       |1         |GWAS       |null      |1.038647111|digestive                                             |gwas           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |irritable bowel syndrome             |EFO_0000555|ENSG00000116329|2.0         |4.0          |\n",
      "|FGFR4         |EFO_0000222|D015470           |FGFR4-D015470  |0.215                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST007847                                                                                    |2019      |null        |null    |0.287970141  |0.69     |1       |0.69       |1         |GWAS       |null      |1.06       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000160867|2.0         |4.0          |\n",
      "|CSF3R         |EFO_0004272|D000740           |CSF3R-D000740  |0.577                            |Anemia                                |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |Genebass    |missenseLC skat continuous both_sexes irnt  |Monocyte percentage                                                                                       |https://genebass.org/gene/ENSG00000119535/phenotype/continuous-30190-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.00095435|null       |hematology                                            |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |anemia (phenotype)                   |EFO_0004272|ENSG00000119535|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0000565|D007938           |ABCB1-D007938  |0.037                            |Leukemia                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |leukemia                             |EFO_0000565|ENSG00000085563|3.0         |4.0          |\n",
      "|IL17F         |EFO_0003778|D015535           |IL17F-D015535  |0.194                            |Arthritis, Psoriatic                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001791      |Blood Platelet Disorders                   |OTG         |null                                        |Mean platelet volume                                                                                      |https://genetics.opentargets.org/study/GCST004599                                                                                    |2016      |null        |null    |0.062294651  |0.58     |1       |0.58       |1         |GWAS       |0.04578266|null       |musculoskeletal, dermatology                          |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |psoriatic arthritis                  |EFO_0003778|ENSG00000112116|3.0         |4.0          |\n",
      "|SCN2A         |EFO_0008526|D013226           |SCN2A-D013226  |0.758                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D003294      |Seizures, Febrile                          |OTG         |null                                        |Febrile seizures [Overall]                                                                                |https://genetics.opentargets.org/study/GCST002672_2                                                                                  |2014      |null        |null    |0.405801868  |0.76     |1       |0.76       |1         |GWAS       |null      |1.22       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000136531|3.0         |4.0          |\n",
      "|TNF           |EFO_0003780|D001528           |TNF-D001528    |0.034                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D015415      |Biomarkers                                 |OTG         |null                                        |Blood protein levels [MICB, 5102_55_3]                                                                    |https://genetics.opentargets.org/study/GCST006585_1148                                                                               |2018      |null        |null    |0.070093458  |0.51     |1       |0.51       |1         |GWAS       |0.9721669 |null       |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000232810|3.0         |4.0          |\n",
      "|KDR           |EFO_0003893|D010051           |KDR-D010051    |0.554                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004715      |Endometriosis                              |OTG         |null                                        |Endometriosis                                                                                             |https://genetics.opentargets.org/study/FINNGEN_R6_N14_ENDOMETRIOSIS                                                                  |2022      |null        |null    |0.283441982  |0.9      |1       |0.9        |1         |GWAS       |null      |1.150273799|oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000128052|2.0         |4.0          |\n",
      "|SCN3A         |EFO_0008526|D013226           |SCN3A-D013226  |0.386                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004827      |Epilepsy                                   |OMIM        |null                                        |Epilepsy, familial focal, with variable foci 4, 617935 (3), Autosomal dominant                            |https://omim.org/entry/182391                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000153253|3.0         |4.0          |\n",
      "|PDCD1         |EFO_0004230|D016889           |PDCD1-D016889  |0                                |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000188389|3.0         |4.0          |\n",
      "|KDR           |EFO_1001513|D008113           |KDR-D008113    |0.246                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2019       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Hemoglobin levels                                                                                         |https://genetics.opentargets.org/study/GCST90025969                                                                                  |2021      |null        |null    |0.03772851   |0.62     |1       |0.62       |1         |GWAS       |0.0303592 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000128052|2.0         |4.0          |\n",
      "|TGFB1         |EFO_0000768|D054990           |TGFB1-D054990  |0.235                            |Idiopathic Pulmonary Fibrosis         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2014       |D010003      |Osteoarthritis                             |OTG         |null                                        |Osteoarthritis                                                                                            |https://genetics.opentargets.org/study/GCST90038686                                                                                  |2021      |null        |null    |0.029411765  |0.66     |1       |0.66       |1         |GWAS       |null      |1.012771366|respiratory                                           |both           |unsupported target          |FALSE       |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |idiopathic pulmonary fibrosis        |EFO_0000768|ENSG00000105329|1.0         |4.0          |\n",
      "|VEGFA         |EFO_0003833|D001932           |VEGFA-D001932  |0.566                            |Brain Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Prostate cancer                                                                                           |https://genetics.opentargets.org/study/GCST011049                                                                                    |2021      |null        |null    |0.501558644  |0.7      |1       |0.7        |1         |GWAS       |null      |1.039      |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |brain neoplasm                       |EFO_0003833|ENSG00000112715|2.0         |4.0          |\n",
      "|FGFR3         |EFO_0003060|D002289           |FGFR3-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.066878568  |0.8      |1       |0.8        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000068078|3.0         |4.0          |\n",
      "|JAK3          |EFO_0002609|D001171           |JAK3-D001171   |0.177                            |Arthritis, Juvenile                   |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D053632      |X-Linked Combined Immunodeficiency Diseases|OMIM        |null                                        |SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive                    |https://omim.org/entry/600173                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |musculoskeletal, dermatology, immune                  |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |juvenile idiopathic arthritis        |EFO_0002609|ENSG00000105639|3.0         |4.0          |\n",
      "|IL17RA        |EFO_0003898|D013167           |IL17RA-D013167 |0.356                            |Spondylitis, Ankylosing               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D002178      |Candidiasis, Chronic Mucocutaneous         |OMIM        |null                                        |Immunodeficiency 51, 613953 (3), Autosomal recessive                                                      |https://omim.org/entry/605461                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |musculoskeletal                                       |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ankylosing spondylitis               |EFO_0003898|ENSG00000177663|3.0         |4.0          |\n",
      "|KIT           |EFO_1001513|D008113           |KIT-D008113    |0.723                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000157404|2.0         |4.0          |\n",
      "|PLG           |EFO_0000612|D009203           |PLG-D009203    |1                                |Myocardial Infarction                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2003       |D009203      |Myocardial Infarction                      |OTG         |null                                        |Myocardial infarction                                                                                     |https://genetics.opentargets.org/study/GCST003117                                                                                    |2015      |null        |null    |0.09060838   |0.81     |1       |0.81       |1         |GWAS       |null      |1.3        |cardiovascular, signs/symptoms                        |gwas           |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |myocardial infarction                |EFO_0000612|ENSG00000122194|3.0         |4.0          |\n",
      "|TOP2A         |EFO_0004230|D016889           |TOP2A-D016889  |0                                |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000131747|3.0         |4.0          |\n",
      "|IFNG          |EFO_0000685|D001172           |IFNG-D001172   |0.349                            |Arthritis, Rheumatoid                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011565      |Psoriasis                                  |OTG         |null                                        |Psoriasis                                                                                                 |https://genetics.opentargets.org/study/GCST005527                                                                                    |2012      |null        |null    |0.025463263  |0.79     |1       |0.79       |1         |GWAS       |null      |11.26126126|musculoskeletal, dermatology, immune                  |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |rheumatoid arthritis                 |EFO_0000685|ENSG00000111537|2.0         |4.0          |\n",
      "|FLT3          |EFO_1001513|D008113           |FLT3-D008113   |0.246                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D006402      |Hematologic Diseases                       |Genebass    |missenseLC burden continuous both_sexes irnt|Monocyte percentage                                                                                       |https://genebass.org/gene/ENSG00000122025/phenotype/continuous-30190-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.0048778 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000122025|2.0         |4.0          |\n",
      "|PDGFRA        |EFO_0003060|D002289           |PDGFRA-D002289 |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007431                                                                                    |2019      |null        |null    |0.200961289  |0.77     |1       |0.77       |1         |GWAS       |0.0173    |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000134853|3.0         |4.0          |\n",
      "|BRAF          |EFO_0003841|D013964           |BRAF-D013964   |0.552                            |Thyroid Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST004894                                                                                    |2017      |null        |null    |0.140890793  |0.77     |1       |0.77       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |thyroid neoplasm                     |EFO_0003841|ENSG00000157764|3.0         |4.0          |\n",
      "|FLT4          |EFO_0003860|D010190           |FLT4-D010190   |0.528                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000037280|2.0         |4.0          |\n",
      "|KDR           |EFO_0003860|D010190           |KDR-D010190    |0.24                             |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Hemoglobin levels                                                                                         |https://genetics.opentargets.org/study/GCST90025969                                                                                  |2021      |null        |null    |0.03772851   |0.62     |1       |0.62       |1         |GWAS       |0.0303592 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000128052|2.0         |4.0          |\n",
      "|IFNAR1        |EFO_0000544|D007239           |IFNAR1-D007239 |0.225                            |Infections                            |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |1989       |D009290      |Narcolepsy                                 |PICCOLO     |Dendritic-cells-Flu                         |narcolepsy                                                                                                |https://www.ncbi.nlm.nih.gov/pubmed/24204295                                                                                         |2013      |2.61E-16    |0.970069|null         |null     |null    |null       |null      |GWAS       |null      |null       |infection                                             |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |infection                            |EFO_0000544|ENSG00000142166|3.0         |4.0          |\n",
      "|SLC5A2        |EFO_0000401|D003928           |SLC5A2-D003928 |0.639                            |Diabetic Nephropathies                |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D006030      |Glycosuria, Renal                          |OMIM        |null                                        |Renal glucosuria, 233100 (3), Autosomal dominant, Autosomal recessive                                     |https://omim.org/entry/182381                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |endocrine                                             |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |diabetic nephropathy                 |EFO_0000401|ENSG00000140675|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0003060|D002289           |ABCB1-D002289  |0.033                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000085563|3.0         |4.0          |\n",
      "|CHRM1         |EFO_1000781|D053201           |CHRM1-D053201  |0.391                            |Urinary Bladder, Overactive           |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2012       |D007319      |Sleep Initiation and Maintenance Disorders |OTG         |null                                        |Insomnia [Female]                                                                                         |https://genetics.opentargets.org/study/GCST007988_2                                                                                  |2019      |null        |null    |0.707829367  |0.51     |1       |0.51       |1         |GWAS       |null      |1.051      |signs/symptoms                                        |gwas           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |overactive bladder                   |EFO_1000781|ENSG00000168539|2.0         |4.0          |\n",
      "|IL2RA         |EFO_0000756|D008545           |IL2RA-D008545  |0.254                            |Melanoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Lymphocyte percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004632                                                                                    |2016      |null        |null    |0.079350649  |0.75     |1       |0.75       |1         |GWAS       |0.03780895|null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |melanoma                             |EFO_0000756|ENSG00000134460|3.0         |4.0          |\n",
      "|BTK           |EFO_0000574|D008223           |BTK-D008223    |0.271                            |Lymphoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |lymphoma                             |EFO_0000574|ENSG00000010671|3.0         |4.0          |\n",
      "|TOP2A         |EFO_0003897|D013274           |TOP2A-D013274  |0                                |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000131747|3.0         |4.0          |\n",
      "|RAF1          |EFO_1001513|D008113           |RAF1-D008113   |0.235                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.356567284  |0.57     |1       |0.57       |1         |GWAS       |0.0206815 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000132155|2.0         |4.0          |\n",
      "|PPARG         |EFO_0001073|D009765           |PPARG-D009765  |1                                |Obesity                               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009765      |Obesity                                    |Genebass    |missenseLC burden continuous both_sexes irnt|Trunk fat mass                                                                                            |https://genebass.org/gene/ENSG00000132170/phenotype/continuous-23128-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.0060003 |null       |metabolic, signs/symptoms                             |both           |genetically supported target|FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |obesity                              |EFO_0001073|ENSG00000132170|2.0         |4.0          |\n",
      "|ADRB1         |EFO_0004287|D014693           |ADRB1-D014693  |0.758                            |Ventricular Fibrillation              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2015       |D001145      |Arrhythmias, Cardiac                       |OTG         |null                                        |PR interval                                                                                               |https://genetics.opentargets.org/study/GCST010320                                                                                    |2020      |null        |null    |0.100831061  |0.78     |1       |0.78       |1         |GWAS       |0.6188    |null       |cardiovascular, signs/symptoms                        |omim/tcga      |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |ventricular fibrillation             |EFO_0004287|ENSG00000043591|3.0         |4.0          |\n",
      "|NR3C1         |EFO_1001110|D047748           |NR3C1-D047748  |0.553                            |Pituitary ACTH Hypersecretion         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2022       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Sex hormone-binding globulin levels adjusted for BMI                                                      |https://genetics.opentargets.org/study/GCST90012110                                                                                  |2020      |null        |null    |0.224565274  |0.9      |1       |0.9        |1         |GWAS       |0.00565119|null       |neurology, endocrine                                  |omim/tcga      |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |pituitary-dependent Cushing's disease|EFO_1001110|ENSG00000113580|3.0         |4.0          |\n",
      "|BCL2          |EFO_0000222|D015470           |BCL2-D015470   |0.697                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2018       |D015451      |Leukemia, Lymphocytic, Chronic, B-Cell     |OTG         |null                                        |Chronic lymphocytic leukemia                                                                              |https://genetics.opentargets.org/study/GCST002073                                                                                    |2013      |null        |null    |0.085690192  |0.82     |1       |0.82       |1         |GWAS       |null      |1.47       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000171791|3.0         |4.0          |\n",
      "|EGFR          |EFO_0003897|D013274           |EGFR-D013274   |0.45                             |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D006484      |Hemorrhoids                                |OTG         |null                                        |Haemorrhoidal disease                                                                                     |https://genetics.opentargets.org/study/GCST90014033                                                                                  |2021      |null        |null    |0.384800104  |0.91     |1       |0.91       |1         |GWAS       |null      |1.029836447|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |stomach neoplasm                     |EFO_0003897|ENSG00000146648|2.0         |4.0          |\n",
      "|BRAF          |EFO_1001513|D008113           |BRAF-D008113   |0.236                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004476      |Ectodermal Dysplasia                       |OMIM        |null                                        |Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant                                             |https://omim.org/entry/164757                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000157764|2.0         |4.0          |\n",
      "|PIK3CD        |EFO_0001378|D009101           |PIK3CD-D009101 |0.714                            |Multiple Myeloma                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008232      |Lymphoproliferative Disorders              |OTG         |null                                        |Monocyte count                                                                                            |https://genetics.opentargets.org/study/GCST90002340                                                                                  |2020      |null        |null    |0.418109621  |0.82     |1       |0.82       |1         |GWAS       |0.022592  |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |multiple myeloma                     |EFO_0001378|ENSG00000171608|2.0         |4.0          |\n",
      "|FGFR2         |EFO_0000222|D015470           |FGFR2-D015470  |0.493                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009369      |Neoplasms                                  |OTG         |null                                        |Malignant neoplasm                                                                                        |https://genetics.opentargets.org/study/FINNGEN_R6_C3_CANCER                                                                          |2022      |null        |null    |0.392197659  |0.92     |1       |0.92       |1         |GWAS       |null      |1.052428131|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000066468|2.0         |4.0          |\n",
      "|PDGFRB        |EFO_0003865|D007680           |PDGFRB-D007680 |0.37                             |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D018224      |Myofibromatosis                            |OMIM        |null                                        |Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant                                             |https://omim.org/entry/173410                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000113721|3.0         |4.0          |\n",
      "|BTK           |EFO_0003060|D002289           |BTK-D002289    |0.232                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000010671|3.0         |4.0          |\n",
      "|IL4R          |EFO_1000391|D009298           |IL4R-D009298   |0.585                            |Nasal Polyps                          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2019       |D012140      |Respiratory Tract Diseases                 |OTG         |null                                        |Chronic lower respiratory diseases                                                                        |https://genetics.opentargets.org/study/FINNGEN_R6_J10_LOWCHRON                                                                       |2022      |null        |null    |0.007192846  |0.81     |1       |0.81       |1         |GWAS       |null      |1.11478326 |respiratory, signs/symptoms                           |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Nasal Cavity Polyp                   |EFO_1000391|ENSG00000077238|2.0         |4.0          |\n",
      "|PDE4C         |EFO_0003780|D001528           |PDE4C-D001528  |0.224                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90019507                                                                                  |2021      |null        |null    |0.279063685  |0.54     |1       |0.54       |1         |GWAS       |0.0275    |null       |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000105650|3.0         |4.0          |\n",
      "|TOP1          |EFO_0003897|D013274           |TOP1-D013274   |0.497                            |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90025966                                                                                  |2021      |null        |null    |0.479155844  |0.65     |1       |0.65       |1         |GWAS       |0.0324091 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000198900|3.0         |4.0          |\n",
      "|BTK           |EFO_0000403|D016403           |BTK-D016403    |0.224                            |Lymphoma, Large B-Cell, Diffuse       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |diffuse large B-cell lymphoma        |EFO_0000403|ENSG00000010671|3.0         |4.0          |\n",
      "|FLT1          |EFO_0003860|D010190           |FLT1-D010190   |0.24                             |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Monocyte percentage of white cells                                                                        |https://genetics.opentargets.org/study/GCST90002394                                                                                  |2020      |null        |null    |0.016874351  |0.77     |1       |0.77       |1         |GWAS       |0.116546  |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000102755|2.0         |4.0          |\n",
      "|IL2RA         |EFO_0000574|D008223           |IL2RA-D008223  |0.538                            |Lymphoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Lymphocyte percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004632                                                                                    |2016      |null        |null    |0.079350649  |0.75     |1       |0.75       |1         |GWAS       |0.03780895|null       |oncology                                              |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |lymphoma                             |EFO_0000574|ENSG00000134460|3.0         |4.0          |\n",
      "|ERBB2         |EFO_0004142|D015179           |ERBB2-D015179  |0.035                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2022       |D018655      |Lymphocyte Count                           |Genebass    |missenseLC skat continuous both_sexes irnt  |Lymphocyte percentage                                                                                     |https://genebass.org/gene/ENSG00000141736/phenotype/continuous-30180-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.00089175|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |colorectal neoplasm                  |EFO_0004142|ENSG00000141736|3.0         |4.0          |\n",
      "|FLT4          |EFO_1001513|D008113           |FLT4-D008113   |0.535                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000037280|2.0         |4.0          |\n",
      "|PDGFRA        |EFO_0003865|D007680           |PDGFRA-D007680 |0.234                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012112                                                                                  |2020      |null        |null    |0.224016969  |0.85     |1       |0.85       |1         |GWAS       |0.0246417 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000134853|3.0         |4.0          |\n",
      "|JAK1          |EFO_0000676|D011565           |JAK1-D011565   |0.475                            |Psoriasis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D056660      |Hereditary Autoinflammatory Diseases       |OMIM        |null                                        |Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3), Autosomal dominant                  |https://omim.org/entry/147795                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |psoriasis                            |EFO_0000676|ENSG00000162434|3.0         |4.0          |\n",
      "|GABRA4        |EFO_0008526|D013226           |GABRA4-D013226 |0.029                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D000124      |Achievement                                |OTG         |null                                        |Educational attainment (MTAG) [MTAG]                                                                      |https://genetics.opentargets.org/study/GCST006571                                                                                    |2018      |null        |null    |0.291720906  |0.55     |1       |0.55       |1         |GWAS       |0.0083    |null       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000109158|3.0         |4.0          |\n",
      "|BRAF          |EFO_1000926|D031249           |BRAF-D031249   |0.201                            |Erdheim-Chester Disease               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004476      |Ectodermal Dysplasia                       |OMIM        |null                                        |Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant                                             |https://omim.org/entry/164757                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |hematology                                            |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Erdheim-Chester disease              |EFO_1000926|ENSG00000157764|2.0         |4.0          |\n",
      "|MAP2K2        |EFO_0004142|D015179           |MAP2K2-D015179 |0.253                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D007970      |Leukopenia                                 |OTG         |null                                        |White blood cell count                                                                                    |https://genetics.opentargets.org/study/GCST007070                                                                                    |2018      |null        |null    |0.09987013   |0.6      |1       |0.6        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |colorectal neoplasm                  |EFO_0004142|ENSG00000126934|2.0         |4.0          |\n",
      "|NR3C1         |EFO_0005628|D011349           |NR3C1-D011349  |0.461                            |Proctitis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90025966                                                                                  |2021      |null        |null    |0.420228661  |0.94     |1       |0.94       |1         |GWAS       |0.0140825 |null       |digestive                                             |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |proctitis                            |EFO_0005628|ENSG00000113580|3.0         |4.0          |\n",
      "|TNFRSF8       |EFO_0002913|D016410           |TNFRSF8-D016410|0.486                            |Lymphoma, T-Cell, Cutaneous           |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004600                                                                                    |2016      |null        |null    |0.011410788  |0.64     |1       |0.64       |1         |GWAS       |0.1043421 |null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Cutaneous T-cell lymphoma            |EFO_0002913|ENSG00000120949|3.0         |4.0          |\n",
      "|CD274         |EFO_0004142|D015179           |CD274-D015179  |0.207                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |colorectal neoplasm                  |EFO_0004142|ENSG00000120217|2.0         |4.0          |\n",
      "|KIT           |EFO_0003865|D007680           |KIT-D007680    |0.534                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000157404|3.0         |4.0          |\n",
      "|PDCD1         |EFO_1001513|D008113           |PDCD1-D008113  |0                                |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2022       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000188389|2.0         |4.0          |\n",
      "|TEK           |EFO_0000222|D015470           |TEK-D015470    |0.2                              |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001165      |Arteriovenous Malformations                |OMIM        |null                                        |Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant                      |https://omim.org/entry/600221                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000120156|2.0         |4.0          |\n",
      "|JAK1          |EFO_0002609|D001171           |JAK1-D001171   |0.265                            |Arthritis, Juvenile                   |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D009103      |Multiple Sclerosis                         |OTG         |null                                        |Multiple sclerosis                                                                                        |https://genetics.opentargets.org/study/GCST009597                                                                                    |2019      |null        |null    |0.100402388  |0.7      |1       |0.7        |1         |GWAS       |null      |1.1642     |musculoskeletal, dermatology, immune                  |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |juvenile idiopathic arthritis        |EFO_0002609|ENSG00000162434|3.0         |4.0          |\n",
      "|PARP1         |EFO_0003860|D010190           |PARP1-D010190  |0.418                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D008545      |Melanoma                                   |OTG         |null                                        |Cutaneous malignant melanoma                                                                              |https://genetics.opentargets.org/study/GCST010304                                                                                    |2020      |null        |null    |0.337015857  |0.8      |1       |0.8        |1         |GWAS       |null      |1.0947     |oncology                                              |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000143799|1.0         |4.0          |\n",
      "|APOC3         |EFO_0004211|D015228           |APOC3-D015228  |1                                |Hypertriglyceridemia                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D015228      |Hypertriglyceridemia                       |Genebass    |missenseLC burden continuous both_sexes irnt|Triglycerides                                                                                             |https://genebass.org/gene/ENSG00000110245/phenotype/continuous-30870-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.017437  |null       |metabolic                                             |both           |genetically supported target|TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Hypertriglyceridemia                 |EFO_0004211|ENSG00000110245|3.0         |4.0          |\n",
      "|IL1B          |EFO_0007135|D016706           |IL1B-D016706   |0.364                            |Still's Disease, Adult-Onset          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006967      |Hypersensitivity                           |OTG         |null                                        |Allergic disease (asthma, hay fever or eczema)                                                            |https://genetics.opentargets.org/study/GCST009716                                                                                    |2019      |null        |null    |0.354859667  |0.74     |1       |0.74       |1         |GWAS       |null      |1.0362694  |musculoskeletal, dermatology, immune                  |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |adult-onset Still's disease          |EFO_0007135|ENSG00000125538|3.0         |4.0          |\n",
      "|ERBB3         |EFO_0003060|D002289           |ERBB3-D002289  |0.22                             |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D007410      |Intestinal Diseases                        |OMIM        |null                                        |Visceral neuropathy, familial, 1, autosomal recessive, 243180 (3), Autosomal recessive                    |https://omim.org/entry/190151                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000065361|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0003060|D002289           |FGFR1-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.41128718   |0.83     |1       |0.83       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000077782|3.0         |4.0          |\n",
      "|IL1B          |EFO_0003914|D050197           |IL1B-D050197   |0.225                            |Atherosclerosis                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006967      |Hypersensitivity                           |OTG         |null                                        |Allergic disease (asthma, hay fever or eczema)                                                            |https://genetics.opentargets.org/study/GCST009716                                                                                    |2019      |null        |null    |0.354859667  |0.74     |1       |0.74       |1         |GWAS       |null      |1.0362694  |cardiovascular                                        |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |atherosclerosis                      |EFO_0003914|ENSG00000125538|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0003893|D010051           |FGFR1-D010051  |0.736                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007006      |Hypogonadism                               |OMIM        |null                                        |Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3), Autosomal dominant                   |https://omim.org/entry/136350                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000077782|2.0         |4.0          |\n",
      "|IL23A         |EFO_0000384|D003424           |IL23A-D003424  |0                                |Crohn Disease                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |digestive                                             |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Crohn's disease                      |EFO_0000384|ENSG00000110944|3.0         |4.0          |\n",
      "|CASR          |EFO_0008519|D049950           |CASR-D049950   |0.528                            |Hyperparathyroidism, Primary          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2019       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST007847                                                                                    |2019      |null        |null    |0.874659401  |0.76     |1       |0.76       |1         |GWAS       |null      |1.05       |endocrine                                             |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |primary hyperparathyroidism          |EFO_0008519|ENSG00000036828|2.0         |4.0          |\n",
      "|CD3E          |EFO_0000756|D008545           |CD3E-D008545   |0.252                            |Melanoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D014923      |Wiskott-Aldrich Syndrome                   |OMIM        |null                                        |Immunodeficiency 18, 615615 (3), Autosomal recessive                                                      |https://omim.org/entry/186830                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |melanoma                             |EFO_0000756|ENSG00000198851|2.0         |4.0          |\n",
      "|NR3C1         |EFO_0004246|D009080           |NR3C1-D009080  |0.489                            |Mucocutaneous Lymph Node Syndrome     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST90002382                                                                                  |2020      |null        |null    |0.560488127  |0.6      |1       |0.6        |1         |GWAS       |0.0142986 |null       |cardiovascular, hematology, dermatology               |both           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |mucocutaneous lymph node syndrome    |EFO_0004246|ENSG00000113580|3.0         |4.0          |\n",
      "|KIT           |EFO_0003860|D010190           |KIT-D010190    |0.714                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |pancreatic neoplasm                  |EFO_0003860|ENSG00000157404|2.0         |4.0          |\n",
      "|CD274         |EFO_0000756|D008545           |CD274-D008545  |0.207                            |Melanoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |melanoma                             |EFO_0000756|ENSG00000120217|3.0         |4.0          |\n",
      "|LYN           |EFO_0003060|D002289           |LYN-D002289    |0.233                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Sum neutrophil eosinophil counts                                                                          |https://genetics.opentargets.org/study/GCST004613                                                                                    |2016      |null        |null    |0.68223205   |0.85     |1       |0.85       |1         |GWAS       |0.02448989|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000254087|2.0         |4.0          |\n",
      "|FGFR1         |EFO_0003865|D007680           |FGFR1-D007680  |0.234                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000077782|2.0         |4.0          |\n",
      "|TEK           |EFO_1001513|D008113           |TEK-D008113    |0.202                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D001165      |Arteriovenous Malformations                |OMIM        |null                                        |Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant                      |https://omim.org/entry/600221                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000120156|2.0         |4.0          |\n",
      "|F10           |EFO_0000612|D009203           |F10-D009203    |0.256                            |Myocardial Infarction                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2021       |D001778      |Blood Coagulation Disorders                |OTG         |null                                        |End-stage coagulation [FVII:C]                                                                            |https://genetics.opentargets.org/study/GCST001798_3                                                                                  |2013      |null        |null    |0.109228972  |0.69     |1       |0.69       |1         |GWAS       |0.534     |null       |cardiovascular, signs/symptoms                        |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |myocardial infarction                |EFO_0000612|ENSG00000126218|3.0         |4.0          |\n",
      "|PDCD1         |EFO_0000702|D055752           |PDCD1-D055752  |0                                |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |small cell lung carcinoma            |EFO_0000702|ENSG00000188389|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0003869|D001943           |ABCB1-D001943  |0.035                            |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000085563|2.0         |4.0          |\n",
      "|KDR           |EFO_0004230|D016889           |KDR-D016889    |0.537                            |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004715      |Endometriosis                              |OTG         |null                                        |Endometriosis                                                                                             |https://genetics.opentargets.org/study/FINNGEN_R6_N14_ENDOMETRIOSIS                                                                  |2022      |null        |null    |0.283441982  |0.9      |1       |0.9        |1         |GWAS       |null      |1.150273799|oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000128052|3.0         |4.0          |\n",
      "|PARP2         |EFO_0003860|D010190           |PARP2-D010190  |0                                |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000129484|1.0         |4.0          |\n",
      "|FLT1          |EFO_0000222|D015470           |FLT1-D015470   |0.241                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Monocyte percentage of white cells                                                                        |https://genetics.opentargets.org/study/GCST90002394                                                                                  |2020      |null        |null    |0.016874351  |0.77     |1       |0.77       |1         |GWAS       |0.116546  |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000102755|3.0         |4.0          |\n",
      "|ADRB2         |EFO_0004287|D014693           |ADRB2-D014693  |0.399                            |Ventricular Fibrillation              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2015       |D006973      |Hypertension                               |OTG         |null                                        |Diastolic blood pressure                                                                                  |https://genetics.opentargets.org/study/GCST90000059                                                                                  |2020      |null        |null    |0.011406351  |0.91     |1       |0.91       |1         |GWAS       |0.03775712|null       |cardiovascular, signs/symptoms                        |omim/tcga      |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |ventricular fibrillation             |EFO_0004287|ENSG00000169252|3.0         |4.0          |\n",
      "|FGFR1         |EFO_1001901|D018358           |FGFR1-D018358  |0.247                            |Neuroendocrine Tumors                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2021       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |neuroendocrine neoplasm              |EFO_1001901|ENSG00000077782|3.0         |4.0          |\n",
      "|MAP2K1        |EFO_0003060|D002289           |MAP2K1-D002289 |0.426                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009373      |Neoplasms, Germ Cell and Embryonal         |PICCOLO     |CD4-meta-cis                                |testicular_germ_cell_tumor                                                                                |https://www.ncbi.nlm.nih.gov/pubmed/28604728                                                                                         |2017      |2.72E-20    |0.907482|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000169032|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0000616|D009369           |ABCB1-D009369  |0.044                            |Neoplasms                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |neoplasm                             |EFO_0000616|ENSG00000085563|2.0         |4.0          |\n",
      "|RET           |EFO_0003897|D013274           |RET-D013274    |0.549                            |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2014       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |stomach neoplasm                     |EFO_0003897|ENSG00000165731|2.0         |4.0          |\n",
      "|PDCD1         |EFO_0003897|D013274           |PDCD1-D013274  |0                                |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000188389|3.0         |4.0          |\n",
      "|KIT           |EFO_0002430|D055728           |KIT-D055728    |0.476                            |Primary Myelofibrosis                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Hemoglobin levels                                                                                         |https://genetics.opentargets.org/study/GCST004005                                                                                    |2016      |null        |null    |0.130694354  |0.83     |1       |0.83       |1         |GWAS       |null      |null       |hematology                                            |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |primary myelofibrosis                |EFO_0002430|ENSG00000157404|1.0         |4.0          |\n",
      "|BRAF          |EFO_0003865|D007680           |BRAF-D007680   |0.235                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004476      |Ectodermal Dysplasia                       |OMIM        |null                                        |Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant                                             |https://omim.org/entry/164757                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000157764|3.0         |4.0          |\n",
      "|KDR           |EFO_0003865|D007680           |KDR-D007680    |0.516                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004715      |Endometriosis                              |OTG         |null                                        |Endometriosis                                                                                             |https://genetics.opentargets.org/study/FINNGEN_R6_N14_ENDOMETRIOSIS                                                                  |2022      |null        |null    |0.283441982  |0.9      |1       |0.9        |1         |GWAS       |null      |1.150273799|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000128052|3.0         |4.0          |\n",
      "|ERBB4         |EFO_0003897|D013274           |ERBB4-D013274  |0.567                            |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001943      |Breast Neoplasms                           |OTG         |null                                        |Breast cancer                                                                                             |https://genetics.opentargets.org/study/GCST001457                                                                                    |2012      |null        |null    |0.088945115  |1        |1       |1          |1         |GWAS       |null      |1.53       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |stomach neoplasm                     |EFO_0003897|ENSG00000178568|1.0         |4.0          |\n",
      "|PPARA         |EFO_0003095|D065626           |PPARA-D065626  |0.198                            |Non-alcoholic Fatty Liver Disease     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D007249      |Inflammation                               |OTG         |null                                        |CTACK levels                                                                                              |https://genetics.opentargets.org/study/GCST004420                                                                                    |2016      |null        |null    |0.717266935  |0.83     |1       |0.83       |1         |GWAS       |0.186     |null       |digestive                                             |both           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |non-alcoholic fatty liver disease    |EFO_0003095|ENSG00000186951|2.0         |4.0          |\n",
      "|C5AR1         |EFO_0006803|D014657           |C5AR1-D014657  |0                                |Vasculitis                            |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |cardiovascular                                        |both           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |vasculitis                           |EFO_0006803|ENSG00000197405|3.0         |4.0          |\n",
      "|FLT4          |EFO_0003893|D010051           |FLT4-D010051   |0.528                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000037280|2.0         |4.0          |\n",
      "|PDGFRA        |EFO_0003893|D010051           |PDGFRA-D010051 |0.599                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012112                                                                                  |2020      |null        |null    |0.224016969  |0.85     |1       |0.85       |1         |GWAS       |0.0246417 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000134853|2.0         |4.0          |\n",
      "|FGFR4         |EFO_0000702|D055752           |FGFR4-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.307667316  |0.69     |1       |0.69       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000160867|2.0         |4.0          |\n",
      "|IL2RA         |EFO_0003865|D007680           |IL2RA-D007680  |0.244                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |1996       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Lymphocyte percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004632                                                                                    |2016      |null        |null    |0.079350649  |0.75     |1       |0.75       |1         |GWAS       |0.03780895|null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000134460|2.0         |4.0          |\n",
      "|RET           |EFO_0003865|D007680           |RET-D007680    |0.556                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2014       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000165731|3.0         |4.0          |\n",
      "|BRAF          |EFO_0003893|D010051           |BRAF-D010051   |0.555                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST004894                                                                                    |2017      |null        |null    |0.140890793  |0.77     |1       |0.77       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000157764|2.0         |4.0          |\n",
      "|RXFP1         |EFO_0003144|D006333           |RXFP1-D006333  |0                                |Heart Failure                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |cardiovascular                                        |both           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |heart failure                        |EFO_0003144|ENSG00000171509|3.0         |4.0          |\n",
      "|ANPEP         |EFO_0000222|D015470           |ANPEP-D015470  |0.226                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (alanine transaminase)                                                                |https://genetics.opentargets.org/study/GCST90013405                                                                                  |2021      |null        |null    |0.093737561  |0.74     |1       |0.74       |1         |GWAS       |0.00623748|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000166825|2.0         |4.0          |\n",
      "|PDE4A         |EFO_0003780|D001528           |PDE4A-D001528  |0.218                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006967      |Hypersensitivity                           |OTG         |null                                        |Inflammatory skin disease [Psoriasis]                                                                     |https://genetics.opentargets.org/study/GCST002740_4                                                                                  |2015      |null        |null    |0.177912116  |0.54     |1       |0.54       |1         |GWAS       |null      |null       |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000065989|3.0         |4.0          |\n",
      "|FLT3          |EFO_0003841|D013964           |FLT3-D013964   |0.697                            |Thyroid Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism or myxedema                                                                                |https://genetics.opentargets.org/study/GCST90038637                                                                                  |2021      |null        |null    |0.014906027  |0.66     |1       |0.66       |1         |GWAS       |null      |1.026185264|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |thyroid neoplasm                     |EFO_0003841|ENSG00000122025|3.0         |4.0          |\n",
      "|TUBB          |EFO_0000702|D055752           |TUBB-D055752   |0.424                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006222      |Hamartoma                                  |OMIM        |null                                        |Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant                     |https://omim.org/entry/191130                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |small cell lung carcinoma            |EFO_0000702|ENSG00000196230|3.0         |4.0          |\n",
      "|FGFR3         |EFO_0000222|D015470           |FGFR3-D015470  |0.4                              |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001749      |Urinary Bladder Neoplasms                  |PICCOLO     |gtex-v6p-adipose-subcutaneous               |bladder_cancer                                                                                            |https://www.ncbi.nlm.nih.gov/pubmed/20972438                                                                                         |2010      |6.04E-15    |0.912895|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000068078|2.0         |4.0          |\n",
      "|JAK2          |EFO_0004208|D014820           |JAK2-D014820   |0.455                            |Vitiligo                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011565      |Psoriasis                                  |OTG         |null                                        |Psoriasis                                                                                                 |https://genetics.opentargets.org/study/GCST005527                                                                                    |2012      |null        |null    |0.016463573  |0.82     |1       |0.82       |1         |GWAS       |null      |8.389261745|dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Vitiligo                             |EFO_0004208|ENSG00000096968|3.0         |4.0          |\n",
      "|FLT3          |EFO_0003865|D007680           |FLT3-D007680   |0.724                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2014       |D051437      |Renal Insufficiency                        |OTG         |null                                        |Creatinine levels                                                                                         |https://genetics.opentargets.org/study/GCST90025946                                                                                  |2021      |null        |null    |0.720277887  |0.78     |1       |0.78       |1         |GWAS       |0.0130199 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000122025|3.0         |4.0          |\n",
      "|EPHA2         |EFO_0003060|D002289           |EPHA2-D002289  |0.224                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Testosterone levels                                                                                       |https://genetics.opentargets.org/study/GCST011518                                                                                    |2021      |null        |null    |0.677792823  |0.59     |1       |0.59       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000142627|3.0         |4.0          |\n",
      "|IL17RA        |EFO_0000717|D012595           |IL17RA-D012595 |0.425                            |Scleroderma, Systemic                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D002178      |Candidiasis, Chronic Mucocutaneous         |OMIM        |null                                        |Immunodeficiency 51, 613953 (3), Autosomal recessive                                                      |https://omim.org/entry/605461                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |systemic scleroderma                 |EFO_0000717|ENSG00000177663|1.0         |4.0          |\n",
      "|CSNK1E        |EFO_0000095|D015451           |CSNK1E-D015451 |0.03                             |Leukemia, Lymphocytic, Chronic, B-Cell|Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D005080      |Exercise Test                              |Genebass    |pLoF skat continuous both_sexes irnt        |Maximum workload during fitness test                                                                      |https://genebass.org/gene/ENSG00000213923/phenotype/continuous-6032-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full |2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.0462    |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |chronic lymphocytic leukemia         |EFO_0000095|ENSG00000213923|3.0         |4.0          |\n",
      "|FLT1          |EFO_0004230|D016889           |FLT1-D016889   |0.489                            |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011225      |Pre-Eclampsia                              |OTG         |null                                        |Preeclampsia (fetal genotype effect)                                                                      |https://genetics.opentargets.org/study/GCST90013475                                                                                  |2020      |null        |null    |0.498830257  |0.62     |1       |0.62       |1         |GWAS       |null      |1.19       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000102755|3.0         |4.0          |\n",
      "|PDE4D         |EFO_0003780|D001528           |PDE4D-D001528  |0.638                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D019226      |Oral Ulcer                                 |OTG         |null                                        |Mouth ulcers                                                                                              |https://genetics.opentargets.org/study/GCST007839                                                                                    |2019      |null        |null    |0.507616196  |0.92     |1       |0.92       |1         |GWAS       |null      |1.0550625  |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000113448|3.0         |4.0          |\n",
      "|ABL1          |EFO_0000222|D015470           |ABL1-D015470   |0.24                             |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007970      |Leukopenia                                 |OTG         |null                                        |White blood cell count                                                                                    |https://genetics.opentargets.org/study/GCST007070                                                                                    |2018      |null        |null    |0.373715929  |0.75     |1       |0.75       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000097007|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0000702|D055752           |FGFR1-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.41128718   |0.83     |1       |0.83       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000077782|2.0         |4.0          |\n",
      "|CD3E          |EFO_0005952|D008228           |CD3E-D008228   |0.515                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D014923      |Wiskott-Aldrich Syndrome                   |OMIM        |null                                        |Immunodeficiency 18, 615615 (3), Autosomal recessive                                                      |https://omim.org/entry/186830                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000198851|3.0         |4.0          |\n",
      "|CHRM4         |EFO_1000781|D053201           |CHRM4-D053201  |0.029                            |Urinary Bladder, Overactive           |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2012       |D012559      |Schizophrenia                              |PICCOLO     |gtex-v6p-nerve-tibial                       |schizophrenia                                                                                             |https://www.ncbi.nlm.nih.gov/pubmed/26198764                                                                                         |2015      |3.44E-08    |0.918717|null         |null     |null    |null       |null      |GWAS       |null      |null       |signs/symptoms                                        |gwas           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |overactive bladder                   |EFO_1000781|ENSG00000180720|2.0         |4.0          |\n",
      "|RET           |EFO_1001513|D008113           |RET-D008113    |0.558                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000165731|2.0         |4.0          |\n",
      "|FLT4          |EFO_0003865|D007680           |FLT4-D007680   |0.534                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000037280|3.0         |4.0          |\n",
      "|FGFR2         |EFO_0000702|D055752           |FGFR2-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.566796621  |0.81     |1       |0.81       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000066468|2.0         |4.0          |\n",
      "|KIT           |EFO_0003841|D013964           |KIT-D013964    |0.526                            |Thyroid Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |thyroid neoplasm                     |EFO_0003841|ENSG00000157404|3.0         |4.0          |\n",
      "|PDE4B         |EFO_0003780|D001528           |PDE4B-D001528  |0.629                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D005764      |Gastroesophageal Reflux                    |OTG         |null                                        |Gastroesophageal reflux disease                                                                           |https://genetics.opentargets.org/study/GCST008832                                                                                    |2019      |null        |null    |0.540398126  |0.97     |1       |0.97       |1         |GWAS       |null      |1.0328273  |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000184588|3.0         |4.0          |\n",
      "|TUBB          |EFO_0003860|D010190           |TUBB-D010190   |0.444                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006222      |Hamartoma                                  |OMIM        |null                                        |Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant                     |https://omim.org/entry/191130                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000196230|3.0         |4.0          |\n",
      "|MAP2K2        |EFO_0003060|D002289           |MAP2K2-D002289 |0.232                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007970      |Leukopenia                                 |OTG         |null                                        |White blood cell count                                                                                    |https://genetics.opentargets.org/study/GCST007070                                                                                    |2018      |null        |null    |0.09987013   |0.6      |1       |0.6        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000126934|3.0         |4.0          |\n",
      "|PARP3         |EFO_1001100|D010534           |PARP3-D010534  |0                                |Peritoneal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |omim/tcga      |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |peritoneal neoplasm                  |EFO_1001100|ENSG00000041880|1.0         |4.0          |\n",
      "|PIK3CD        |EFO_0000222|D015470           |PIK3CD-D015470 |0.554                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009373      |Neoplasms, Germ Cell and Embryonal         |OTG         |null                                        |Testicular germ cell tumor                                                                                |https://genetics.opentargets.org/study/GCST004635                                                                                    |2017      |null        |null    |0.418903075  |0.82     |1       |0.82       |1         |GWAS       |null      |1.14       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000171608|2.0         |4.0          |\n",
      "|IL5RA         |EFO_1000391|D009298           |IL5RA-D009298  |0.223                            |Nasal Polyps                          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004600                                                                                    |2016      |null        |null    |0.618628601  |0.72     |1       |0.72       |1         |GWAS       |0.02797388|null       |respiratory, signs/symptoms                           |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Nasal Cavity Polyp                   |EFO_1000391|ENSG00000091181|3.0         |4.0          |\n",
      "|IFNAR2        |EFO_0006510|D006562           |IFNAR2-D006562 |0.244                            |Herpes Zoster                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST90002382                                                                                  |2020      |null        |null    |0.448705992  |0.53     |1       |0.53       |1         |GWAS       |0.0138217 |null       |infection                                             |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Herpes Zoster                        |EFO_0006510|ENSG00000159110|3.0         |4.0          |\n",
      "|JAK3          |EFO_0000676|D011565           |JAK3-D011565   |0.185                            |Psoriasis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D053632      |X-Linked Combined Immunodeficiency Diseases|OMIM        |null                                        |SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive                    |https://omim.org/entry/600173                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |psoriasis                            |EFO_0000676|ENSG00000105639|3.0         |4.0          |\n",
      "|IL2RA         |EFO_0003869|D001943           |IL2RA-D001943  |0.494                            |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004485      |Eczema                                     |OTG         |null                                        |Eczema                                                                                                    |https://genetics.opentargets.org/study/GCST007075                                                                                    |2018      |null        |null    |0.079350649  |0.83     |1       |0.83       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000134460|1.0         |4.0          |\n",
      "|PDCD1         |EFO_0003869|D001943           |PDCD1-D001943  |0                                |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000188389|3.0         |4.0          |\n",
      "|PDGFRB        |EFO_0003860|D010190           |PDGFRB-D010190 |0.367                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D018224      |Myofibromatosis                            |OMIM        |null                                        |Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant                                             |https://omim.org/entry/173410                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000113721|2.0         |4.0          |\n",
      "|PDGFRB        |EFO_0003893|D010051           |PDGFRB-D010051 |0.367                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D018224      |Myofibromatosis                            |OMIM        |null                                        |Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant                                             |https://omim.org/entry/173410                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000113721|2.0         |4.0          |\n",
      "|CSF1R         |EFO_0003865|D007680           |CSF1R-D007680  |0.244                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Granulocyte percentage of myeloid white cells                                                             |https://genetics.opentargets.org/study/GCST004608                                                                                    |2016      |null        |null    |0.633411581  |0.58     |1       |0.58       |1         |GWAS       |0.03435342|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000182578|3.0         |4.0          |\n",
      "|ALOX5         |EFO_0000341|D029424           |ALOX5-D029424  |0.224                            |Pulmonary Disease, Chronic Obstructive|Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2007       |D000740      |Anemia                                     |OTG         |null                                        |Mean corpuscular hemoglobin                                                                               |https://genetics.opentargets.org/study/GCST007068                                                                                    |2018      |null        |null    |0.202936209  |0.64     |1       |0.64       |1         |GWAS       |null      |null       |respiratory                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |chronic obstructive pulmonary disease|EFO_0000341|ENSG00000012779|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0000222|D015470           |FGFR1-D015470  |0.232                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000077782|2.0         |4.0          |\n",
      "|EZH2          |EFO_0005952|D008228           |EZH2-D008228   |0.455                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |D000740      |Anemia                                     |OTG         |null                                        |Red cell distribution width                                                                               |https://genetics.opentargets.org/study/GCST007074                                                                                    |2018      |null        |null    |0.474047092  |0.77     |1       |0.77       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000106462|1.0         |4.0          |\n",
      "|F10           |EFO_1000985|D000789           |F10-D000789    |0.227                            |Angina, Unstable                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2021       |D001778      |Blood Coagulation Disorders                |OTG         |null                                        |End-stage coagulation [FVII:C]                                                                            |https://genetics.opentargets.org/study/GCST001798_3                                                                                  |2013      |null        |null    |0.109228972  |0.69     |1       |0.69       |1         |GWAS       |0.534     |null       |cardiovascular, signs/symptoms                        |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |intermediate coronary syndrome       |EFO_1000985|ENSG00000126218|3.0         |4.0          |\n",
      "|TOP2A         |EFO_0000174|D012512           |TOP2A-D012512  |0                                |Sarcoma, Ewing                        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Ewing sarcoma                        |EFO_0000174|ENSG00000131747|3.0         |4.0          |\n",
      "|FLT1          |EFO_0003893|D010051           |FLT1-D010051   |0.505                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011225      |Pre-Eclampsia                              |OTG         |null                                        |Preeclampsia (fetal genotype effect)                                                                      |https://genetics.opentargets.org/study/GCST90013475                                                                                  |2020      |null        |null    |0.498830257  |0.62     |1       |0.62       |1         |GWAS       |null      |1.19       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000102755|2.0         |4.0          |\n",
      "|NR3C1         |EFO_0003872|D003092           |NR3C1-D003092  |0.513                            |Colitis                               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |1999       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90025966                                                                                  |2021      |null        |null    |0.420228661  |0.94     |1       |0.94       |1         |GWAS       |0.0140825 |null       |digestive                                             |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |colitis                              |EFO_0003872|ENSG00000113580|3.0         |4.0          |\n",
      "|PPARA         |EFO_0001073|D009765           |PPARA-D009765  |1                                |Obesity                               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009765      |Obesity                                    |OTG         |null                                        |Weight                                                                                                    |https://genetics.opentargets.org/study/GCST90018729                                                                                  |2021      |null        |null    |0.203619616  |0.55     |1       |0.55       |1         |GWAS       |0.0349198 |null       |metabolic, signs/symptoms                             |both           |genetically supported target|FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |obesity                              |EFO_0001073|ENSG00000186951|2.0         |4.0          |\n",
      "|HDAC10        |EFO_0003869|D001943           |HDAC10-D001943 |0                                |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000100429|1.0         |4.0          |\n",
      "|PDGFRA        |EFO_1001513|D008113           |PDGFRA-D008113 |0.235                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012112                                                                                  |2020      |null        |null    |0.224016969  |0.85     |1       |0.85       |1         |GWAS       |0.0246417 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000134853|2.0         |4.0          |\n",
      "|JAK1          |EFO_0004208|D014820           |JAK1-D014820   |0.455                            |Vitiligo                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D056660      |Hereditary Autoinflammatory Diseases       |OMIM        |null                                        |Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3), Autosomal dominant                  |https://omim.org/entry/147795                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Vitiligo                             |EFO_0004208|ENSG00000162434|3.0         |4.0          |\n",
      "|CD274         |EFO_0003897|D013274           |CD274-D013274  |0.2                              |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000120217|2.0         |4.0          |\n",
      "|FLT1          |EFO_1001513|D008113           |FLT1-D008113   |0.246                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Monocyte percentage of white cells                                                                        |https://genetics.opentargets.org/study/GCST90002394                                                                                  |2020      |null        |null    |0.016874351  |0.77     |1       |0.77       |1         |GWAS       |0.116546  |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000102755|2.0         |4.0          |\n",
      "|BCR           |EFO_0000222|D015470           |BCR-D015470    |0.03                             |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007839      |Functional Laterality                      |OTG         |null                                        |Left-handedness                                                                                           |https://genetics.opentargets.org/study/GCST90013421                                                                                  |2020      |null        |null    |0.597516578  |0.66     |1       |0.66       |1         |GWAS       |null      |1.022348476|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000186716|3.0         |4.0          |\n",
      "+--------------+-----------+------------------+---------------+---------------------------------+--------------------------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+-------------------------------------------+------------+--------------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+----------+------------+--------+-------------+---------+--------+-----------+----------+-----------+----------+-----------+------------------------------------------------------+---------------+----------------------------+------------+------------+-----------+----------------+------+-----------+------+-------------------------------------+-----------+---------------+------------+-------------+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### cases where Nelson is Phase 4 and Chembl below 4\n",
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Print diseases from T-D where Pharmaprojects is launched and ChEMBL appears below"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------------------------------+-----+\n",
      "|label                                |count|\n",
      "+-------------------------------------+-----+\n",
      "|non-small cell lung carcinoma        |14   |\n",
      "|kidney neoplasm                      |14   |\n",
      "|liver neoplasm                       |13   |\n",
      "|acute myeloid leukemia               |11   |\n",
      "|pancreatic neoplasm                  |10   |\n",
      "|ovarian neoplasm                     |9    |\n",
      "|stomach neoplasm                     |7    |\n",
      "|breast neoplasm                      |6    |\n",
      "|small cell lung carcinoma            |6    |\n",
      "|Behcet's syndrome                    |5    |\n",
      "|endometrial neoplasm                 |5    |\n",
      "|status epilepticus                   |4    |\n",
      "|non-Hodgkins lymphoma                |4    |\n",
      "|colorectal neoplasm                  |4    |\n",
      "|ventricular fibrillation             |3    |\n",
      "|thyroid neoplasm                     |3    |\n",
      "|melanoma                             |3    |\n",
      "|Vitiligo                             |2    |\n",
      "|chronic lymphocytic leukemia         |2    |\n",
      "|primary myelofibrosis                |2    |\n",
      "|psoriasis                            |2    |\n",
      "|obesity                              |2    |\n",
      "|ankylosing spondylitis               |2    |\n",
      "|idiopathic pulmonary fibrosis        |2    |\n",
      "|myocardial infarction                |2    |\n",
      "|non-alcoholic fatty liver disease    |2    |\n",
      "|psoriatic arthritis                  |2    |\n",
      "|juvenile idiopathic arthritis        |2    |\n",
      "|overactive bladder                   |2    |\n",
      "|Nasal Cavity Polyp                   |2    |\n",
      "|neuroblastoma                        |2    |\n",
      "|lymphoma                             |2    |\n",
      "|pituitary-dependent Cushing's disease|2    |\n",
      "|rheumatoid arthritis                 |2    |\n",
      "|neoplasm                             |1    |\n",
      "|Erdheim-Chester disease              |1    |\n",
      "|Hodgkins lymphoma                    |1    |\n",
      "|atherosclerosis                      |1    |\n",
      "|adult-onset Still's disease          |1    |\n",
      "|Mastocytosis                         |1    |\n",
      "|colitis                              |1    |\n",
      "|Crohn's disease                      |1    |\n",
      "|Hypertriglyceridemia                 |1    |\n",
      "|heart failure                        |1    |\n",
      "|cardiovascular disease               |1    |\n",
      "|diabetic nephropathy                 |1    |\n",
      "|diffuse large B-cell lymphoma        |1    |\n",
      "|mucocutaneous lymph node syndrome    |1    |\n",
      "|Herpes Zoster                        |1    |\n",
      "|multiple myeloma                     |1    |\n",
      "|polycythemia vera                    |1    |\n",
      "|medulloblastoma                      |1    |\n",
      "|Sjogren syndrome                     |1    |\n",
      "|nasopharyngeal neoplasm              |1    |\n",
      "|Cutaneous T-cell lymphoma            |1    |\n",
      "|proctitis                            |1    |\n",
      "|neuroendocrine neoplasm              |1    |\n",
      "|nicotine dependence                  |1    |\n",
      "|anemia (phenotype)                   |1    |\n",
      "|dry eye syndrome                     |1    |\n",
      "|irritable bowel syndrome             |1    |\n",
      "|vasculitis                           |1    |\n",
      "|chronic obstructive pulmonary disease|1    |\n",
      "|sinusitis                            |1    |\n",
      "|brain neoplasm                       |1    |\n",
      "|peritoneal neoplasm                  |1    |\n",
      "|lipodystrophy                        |1    |\n",
      "|Ewing sarcoma                        |1    |\n",
      "|intermediate coronary syndrome       |1    |\n",
      "|benign prostatic hyperplasia         |1    |\n",
      "|systemic scleroderma                 |1    |\n",
      "|leukemia                             |1    |\n",
      "|primary hyperparathyroidism          |1    |\n",
      "|infection                            |1    |\n",
      "+-------------------------------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### Diseases from cases where Nelson is Phase 4 and Chembl below 2\n",
    "\n",
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").groupBy(\n",
    "    \"label\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Print genes from T-D where Pharmaprojects is launched and ChEMBL appears below"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+-----+\n",
      "|approvedSymbol|count|\n",
      "+--------------+-----+\n",
      "|FGFR1         |8    |\n",
      "|FLT1          |7    |\n",
      "|KIT           |6    |\n",
      "|BRAF          |6    |\n",
      "|FGFR3         |6    |\n",
      "|PDCD1         |6    |\n",
      "|IL2RA         |5    |\n",
      "|KDR           |5    |\n",
      "|FLT4          |5    |\n",
      "|TOP2A         |5    |\n",
      "|CD274         |4    |\n",
      "|BTK           |4    |\n",
      "|RET           |4    |\n",
      "|PDGFRA        |4    |\n",
      "|FGFR2         |4    |\n",
      "|ABCB1         |4    |\n",
      "|NR3C1         |4    |\n",
      "|VEGFA         |3    |\n",
      "|PDGFRB        |3    |\n",
      "|IL17RA        |3    |\n",
      "|JAK1          |3    |\n",
      "|FGFR4         |3    |\n",
      "|FLT3          |3    |\n",
      "|IL1B          |2    |\n",
      "|IL17F         |2    |\n",
      "|ERBB4         |2    |\n",
      "|F10           |2    |\n",
      "|TUBB          |2    |\n",
      "|CD3E          |2    |\n",
      "|PIK3CD        |2    |\n",
      "|PPARA         |2    |\n",
      "|CSF1R         |2    |\n",
      "|IL4R          |2    |\n",
      "|APOC3         |2    |\n",
      "|JAK3          |2    |\n",
      "|TEK           |2    |\n",
      "|MAP2K2        |2    |\n",
      "|MAP2K1        |2    |\n",
      "|LYN           |2    |\n",
      "|CHRM1         |1    |\n",
      "|TOP1          |1    |\n",
      "|EZH2          |1    |\n",
      "|CYP11B2       |1    |\n",
      "|CD19          |1    |\n",
      "|GABRA4        |1    |\n",
      "|IFNAR2        |1    |\n",
      "|PLG           |1    |\n",
      "|CHRM4         |1    |\n",
      "|PDE4B         |1    |\n",
      "|IL6           |1    |\n",
      "|IFNG          |1    |\n",
      "|NR1H4         |1    |\n",
      "|OPRD1         |1    |\n",
      "|PARP1         |1    |\n",
      "|CD276         |1    |\n",
      "|JAK2          |1    |\n",
      "|SCN3A         |1    |\n",
      "|TGFB1         |1    |\n",
      "|TNFRSF8       |1    |\n",
      "|SCN5A         |1    |\n",
      "|PLAT          |1    |\n",
      "|ERBB2         |1    |\n",
      "|RXFP1         |1    |\n",
      "|FKBP1A        |1    |\n",
      "|CASR          |1    |\n",
      "|HDAC10        |1    |\n",
      "|EPHA2         |1    |\n",
      "|PARP2         |1    |\n",
      "|C5AR1         |1    |\n",
      "|ANPEP         |1    |\n",
      "|PPARG         |1    |\n",
      "|ADRB1         |1    |\n",
      "|BCR           |1    |\n",
      "|CSNK1E        |1    |\n",
      "|TYMS          |1    |\n",
      "|IL5RA         |1    |\n",
      "|ADRB2         |1    |\n",
      "|PDE4C         |1    |\n",
      "|SCN1A         |1    |\n",
      "|TNF           |1    |\n",
      "|ALOX5         |1    |\n",
      "|IFNAR1        |1    |\n",
      "|EGFR          |1    |\n",
      "|SCN2A         |1    |\n",
      "|IL23A         |1    |\n",
      "|GNRHR         |1    |\n",
      "|ABL1          |1    |\n",
      "|BCL2          |1    |\n",
      "|CNR1          |1    |\n",
      "|CSF3R         |1    |\n",
      "|RAF1          |1    |\n",
      "|SLC5A2        |1    |\n",
      "|PARP3         |1    |\n",
      "|PDE4A         |1    |\n",
      "|AR            |1    |\n",
      "|ERBB3         |1    |\n",
      "|PDE4D         |1    |\n",
      "+--------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### Targets from cases where Nelson is Phase 4 and Chembl below 2\n",
    "\n",
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").groupBy(\n",
    "    \"approvedSymbol\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "PySpark",
   "language": "python",
   "name": "pyspark"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
